University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

8-1993

Energy restriction effects on splanchnic and peripherial tissue
metabolite fluxes with or without the addition of Lasalocid
Louis N. Lembo

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes

Recommended Citation
Lembo, Louis N., "Energy restriction effects on splanchnic and peripherial tissue metabolite fluxes with or
without the addition of Lasalocid. " Master's Thesis, University of Tennessee, 1993.
https://trace.tennessee.edu/utk_gradthes/6915

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Louis N. Lembo entitled "Energy restriction effects
on splanchnic and peripherial tissue metabolite fluxes with or without the addition of Lasalocid."
I have examined the final electronic copy of this thesis for form and content and recommend
that it be accepted in partial fulfillment of the requirements for the degree of Master of Science,
with a major in Animal Science.
R.N. Heitmann, Major Professor
We have read this thesis and recommend its acceptance:
J.D. Quigley III, J.D. Godkin, F.M. Hopkins
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:

.

,

t

•

ht

I am submitting herewith a thesis written by Louis N.
Lembo entitled "Energy Restriction Effects on Splanchnic
an??e??p?;er1f
Metabolite Fluxes with or without the
Addition of Lasalocid". I have examined the

this thesis for form and content and recommend that it be

accLterin partial fulfillment of the requirements for the

degrL of Master of Science, with a major in Animal Science.
•n V

. N. Heitmann, Major Professor

R

We have read this thesis

and recommend its acceptance

Accepted for the Council

Associate Vice Chancellor and
Dean of the Graduate School

STATEMENT OF PERMISSION TO USE

In presenting this thesis in partial fulfillment of the
requirements for a Master's degree at The University of
Tennessee, Knoxville, I agree that the Library shall make it
available to borrowers under the rules of the Library.

Brief quotations from this thesis are allowable without

special pennission, provided that accurate acknowledgment of
the source is made.

Permission for extensive quotation from or reproduction

of this thesis may be granted by my major professor, or in
his absence, by the Head of Interlibrary Services when, in

the opinion of either, the proposed use of the material is
for scholarly purposes. Any copying or use of the material
in this thesis for financial gain shall not be allowed
without my written permission.

Signature

Date

7/^9;/9:?

Energy Restriction Effects on Splanchnic and
Peripherial Tissue Metabolite Fluxes
with or without the Addition
of Lasalocid

A Thesis
Presented for the

Master of Science Degree
The University of Tennessee
Knoxville, Tennessee

Louis N. Lembo

August 1993

Afi-VET-«D.

3

ACKNOWLEDGMENTS

The author wishes to extend his gratitude and

appreciation to the following individuals who have assisted
in some way towards the achievement of his Master of
Science degree:

Dr. Richard N. Heitmann, for the wisdom imparted,

guidance, friendship and patience that will always be
remembered.

Jennifer Campbell, for all your help and friendship,

for your perseverance in seeing to it that the job was done
right, and for showing me how to live the high life.
Byron Housewright, for all your help in the lab and
with life and for your friendship.

Deborah Randolph, your friendship and advice will
always be remembered.

Dr. Jim Neel, for taking me places and protecting me

once we got there, and for your help and guidance along the
way.

And finally, the author extends many thanks to Mom and
Dad, Patsy, Jules Dore, Scott Smith, and the members of my
committee. Dr. J. D. Quigley III, Dr. J. D. Godkin and Dr.

F. M. Hopkins for the little things that meant so much.

11

ABSTRACT

Concentration and net fluxes of glucose (GLU),

nonesterifled fatty acids (NEFA), acetoacetate (ACAC), Shydroxybutyrate (BOHB) and volatile fatty acids (VFA) were
studied in mature, non-pregnant, non-lactating ewes with or
without the addition of the ionophore Lasalocid.

Chronic

indwelling catheters were placed in portal, hepatic and
mesenteric veins, and the caudal vena cava and aorta at

least 14 days prior to experiments.

Ewes were fed alfalfa

pellets at 100% or 50% of the NRC metabolizable energy
requirement during the first study.

During the second

study, the feeding regimen was identical except for the

addition of Lasalocid (44 mg/kg) to the fed.

On experiment

days, paraaminohippurate (PAH, 1.5% @ .764 ml/min.) was
infused via the mesenteric catheter in order to measure
blood flow across down stream tissues.

After a one hour

equilibration period, a series of 6 samples (12 ml) were
drawn simultaneously at 30 min. intervals from the portal
and hepatic veins and the caudal vena cava and aorta.

Flux

rates were calculated by multiplying venoarterial (V-A)
differences by blood flow rates across the respective
tissue.

Rump V-A differences were calculated instead of

flux rates because a simultaneous blood flow could not be
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measured.
BOHB.

Whole blood was analyzed for PAH, GLU, ACAC and

Plasma was analyzed for NEFA and VFA's.

During the first study, energy restriction (ER)
reduced splanchnic blood flow specifically at the expense

of the portal vein contribution to the liver (HEP)
indicating that a larger percentage of peripherally
released metabolites reached the liver.

Energy restriction

also decreased (P<.05) arterial glucose from 2.68 to 2.41
mM due to increased (P<.05) glucose uptake by portaldrained viscera (PDV).

unchanged.

Liver GLU release (30 mmol/h) was

NEFA arterial concentrations increased (P<.01)

2 fold due to a 3 fold increase (P<.01) in rump release and

despite a 2.5 fold increase (P<.01) in hepatic uptake.
Hepatic extraction of NEFA also increased (P<.01) by 50%.
Because HEP NEFA uptake increased during ER, HEP release of
ACAC decreased (P<.01), while release of BOHB increased
(P<.05) 2 fold.

However, PDV release of both ketones

decreased -60% (P<.05, ACAC; P<.05, BOHB) due to the energy
restriction.

Arterial acetate concentration decreased

(P<.01) during ER by 36% due to a decrease (P<.01) in PDV

release of ~50% (927 to 439 /xmol/min).

There was no

significant HEP flux of acetate, but rump uptake decreased
(P<.01) 43%, dependent upon concentration.

Arterial

propionate concentration was unaffected by ER despite a
decrease (P<.01) of 60% in PDV release due to a concomitant
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decrease (P<.01) of 60% in HEP uptake.

Rump uptake of

propionate was not affected by ER, remaining constant at
-25-35% of circulating concentrations.

Arterial butyrate

concentrations statistically decreased (P<.01) from 8 to 5

with ER, however, this may not be physiologically

significant because both PDV release and HEP uptake
decreased (P<.01) resulting in no change in total

splanchnic output.

This work demonstrates that decreasing

ME intake by 50% increases the animals reliance on

endogenous fuels (i.e. hepatic ketogenesis and peripheral
lypolysis) because potential ME from VFA PDV release
decreased probably due to decreased organic matter
fermentation.

During the second study, energy restriction did not
change splanchnic blood flow.

Arterial glucose

concentration actually increased (P<.01) from 2.36 to 2.56

mM despite a decease (P<.05) in total splanchnic release of
40%. Liver release of GLU was not statistically different,

however, it was approx. 33% lower than what was expected
(20 vs. 30 mmol/h).

NEFA arterial concentrations increased

(P<.01) 2 fold despite a 2 fold increase (P<.01) in hepatic

uptake and a switch from rump release to utilization
(P<.01).

Arterial ACAC concentrations did not change

despite a decrease (P<.01) of 60% in portal vein viscera
(PDV) release.

BOHB arterial concentrations increased

(P<.01) due to an increase {P<.01) in HEP production of
45%.

Acetate arterial concentrations decreased (P<.01), as

did portal concentrations.

PDV acetate release decreased

(P<.01) almost 65%, resulting in decreased (P<.01) TSP
release.

Propionate arterial concentrations decreased

(P<.01) almost 50%, while portal concentrations decreased
(P<.01) almost 65%.

almost 75%.

PDV release of propionate decreased

HEP propionate uptake decreased nearly 70%.

However, TSP release still saw a decrease {P<.01) from 31

to 2 /imol/min.

Butyrate arterial concentrations decreased

(P<.01), as did portal concentrations.

There was no change

in TSP butyrate release, despite a decrease (P<.01) of 65%
in PDV release.
66%.

HEP butyrate uptake also decreased (P<.01)

Valerate portal concentrations decreased (P<.05) 40%.

PDV release of valerate decreased (P<.05) 40%, as did HEP

uptake.

There were no significant net flux changes with

either of the branched chain volatile fatty acids,
isobutyrate and isovalerate.

VI

"There is no subject more captivating, more worthy of study
than nature. To understand this great mechanism, to
discover the forces which are active, and the laws which

govern them, is the highest aim of the intellect of man"
Nikola Tesla, 1891
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CHAPTER 1
INTRODUCTION

The body remains in a dynamic state, ever changing, in
order to react to a wide variety of factors, ranging from

changes in the environment to changes in the diet.

An

animal must be able to adapt to these changes in order to

survive and reproduce to insure the survival of the

species.

An animal, or species, which can not successfully

adapt to an ever changing environment will die off and
become extinct.

Most of the classic mechanistic work was performed on

animals in a post-absorptive state.

In the ruminant, a

three day fast is required before the animal is considered
to be in a post-absorptive state.

However, in practice,

fasting probably only occurs in response to an other, more
serious condition, such as a disease state.

A more

realistic scenario that would be encountered in the field

is a partial energy restriction, perhaps due to inadequate
trough space, or environmental conditions, such as flooding
or snow cover.

Therefore, the first study was conducted to

quantify the metabolic responses which occur in ewes
adapting to restrictions in energy intake.

lonophores have been shown to decrease feed-to-gain
ratios, thus making the animal more efficient.

The second

part of this study was conducted to determine whether this

increased efficiency could be demonstrated in animals in a
negative energy balance.

CHAPTER 2
REVIEW OF LITERATURE
ENERGY METABOLISM

Glucose Production:

There are three primary sources which provide glucose
to the ruminant animal: the gastrointestinal tract (via

absorption), liver and kidneys.

Depending upon the diet,

very little glucose is provided via the GI tract, in fact,
portal utilization may account for up to 20% of glucose
turnover (Bergman, et al,, 1970).

This may appear

paradoxical since most of what is fed to a ruminant is rich
in glucose, such as cellulose and starches.

These

compounds are broken down in the rumen to their basic
monosaccharide constituents, however, rumen microorganisms
utilize these monosaccharides as substrates to produce
various end-products, among them: acetate, butyrate and

propionate (Katz and Bergman, 1969a).

The end result is

that little or no glucose will by-pass the rumen to be

absorbed directly by the small intestines. (Roe, et al.,
1966)

Minimal glucose absorption directly from the diet
places the ruminant animal in a peculiar situation.

Since

glucose derived directly from the diet is inadequate to met
the animal's needs, ruminants must rely entirely upon

gluconeogenesis for their glucose supply (Baird, 1977;

Heitmann, et al., 1986).

Bergman (1973) estimated that

approximately 98% of a ruminant's glucose demand was met
through liver and kidney glucose production, the majority
of which being derived from the liver (Katz and Bergman,
1969b).

Substrates for gluconeogenesis generally fall into

four categories: 1) propionate, 2) amino acids, 3) glycerol
and 4) lactate and pyruvate.

The rate of gluconeogenesis

is dependent upon the rate at which these precursors are

supplied to glucogenic tissues.

Other substrates, such as

valerate and isobutyrate, can contribute to net glucose

production, however they are present in too small a

quantity to be of major physiological importance (Bergman,
1973).

The relative contributions of each of the major

substrates varies according to the animals energy balance.

For example, in the fed state, propionate and lactate will
be readily available from rumen fermentation, and may
account for up to 80% of net glucose production (Baird,
1977).

In the fasted state, propionate, which is derived

exclusively from ruminal fermentation, will be low (Bergman
et al., 1966).

However, there will be an increased

glycerol release from the breakdown of triglycerides in

adipose tissue which can partially relieve the shortage of
gluconeogenic substrates (Heitmann, et al., 1986).

Propionate is the only major volatile fatty acid (VFA)
that can contribute directly to gluconeogenesis.

Net

glucose production from propionate can occur because
propionate enters the TCA cycle at succinate and therefore

none of the molecule is lost as CO2 (Figure 1).
The majority of glucose production which occurs
directly from propionate occurs in the liver simply because
circulating levels of propionate are low (Cook and Miller,

1966).

The liver, which is the first major tissue

downstream of the digestive tract, extracts about 90% of

the propionate which is presented to it and is quite
efficient at converting propionate into glucose.

Leng

(1970) estimated that 50% to 60% of the propionate taken up
by the liver is converted directly to glucose.

Propionate may also contribute indirectly to glucose
production via conversion to lactate in rumen epithelium,
which may account for 1.0 to 4.6% of the propionate
absorbed by the epithelium (Weigand, et al., 1972).

Since

circulating levels of lactate are generally higher than
circulating levels of propionate, glucose production in the
kidneys may be stimulated by an increase in ruminal
propionate production.

However, glucose production from

propionate, either directly or indirectly, would not exceed
two-thirds of the total glucose production from
gluconeogenic substrates (Bergman, 1973).
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Figure 1
The TCA Cycle

Amino acids are a second major source of gluconeogenic

substrates.

Heitmann and Bergman (1978) estimated that

almost 30% of glucose in whole blood may be derived from
six amino acids.

Over 25% of the total glucose came from

just three: glutamate, glutamine and alanine.
The first step towards gluconeogenesis for an amino
acid involves the removal of the amino group, via
transamination or oxidative deamination.

Transamination is

used in muscle cells to transport the toxic amino groups to
the liver for urea formation.

Transamination is

accomplished by transferal of an amino group from an amino
acid to an aketo-acid, such as aketogluterate or

oxaloacetate to alanine or glutamine, respectively.

The

new amino acid is then transferred via the blood stream to

the liver for deamination and use as a substrate for

gluconeogenesis.
Other cells, such as those of the gut, which release

little or no glutamate or glutamine, rid amino acids of
their amino groups via oxidative deamination.

This pathway

results in the formation of an aketo-acid and a free
ammonium ion.

The ammonium ion can then either be

metabolized in the liver to form urea or can be shuttled

back to the rumen for incorporation into amino acids by
rumen microorganisms.

Glycerol is probably not a very important

gluconeogenic precursor in the fed ruminant.

The main

function of glycerol is to serve as the backbone for

triglycerides in adipose tissue.

However, since adipose

tissue possesses insufficient glycerokinase activity to

produce the glycerol-3-phosphate from glycerol needed for
both gluconeogenesis and triglyceride synthesis (Bauman,
1976), triglyceride breakdown results in an unusable
endproduct: glycerol.

The glycerol molecule can be

transported to the liver, which possesses glycerolkinase
activity, for subsequent metabolism to glucose via triosephosphate.

Conversion of glycerol into glucose does not

involve the TCA cycle (Figure 1).

During times of metabolic stress, there is
mobilization of body fat stores and an associated
concomitant rise in glycerol release from adipose tissue.
This added glycerol may be used to replace some of the
glucogenic substrates that are limited in the diet or
provide supplementary substrates when glucose turnover rate
increases.

Thus while glycerol may be relatively

unimportant in the fed animal, it can play a major role in
times of stress, possibly accounting for up to 40% of the

ruminant animals glucose production (Bergman, 1973).
The final major pathway for gluconeogenesis involves
lactate, pyruvate and the Cori cycle.

Circulating lactate

must be separated into two components: that derived from

the Cori cycle and that derived from ruminal fermentation.
Cori cycle derived lactate conversion to glucose can not be
considered true net glucose production, while ruminally
derived lactate can contribute to net glucose production.
The Cori cycle involves conversion of glucose to lactate,

usually under periods of oxygen shortage or intense work
(e.g. muscle during exercise).

Lactate can then be

transported to the liver or kidneys for subsequent
conversion to glucose.

This cycle allows for the use of

lactate by tissues which do not posses the ability to
metabolize lactate directly.
Lactate can be converted to pyruvate by the enzyme
lactate dehydrogenase. Pyruvate may also be released from

working tissue during anaerobic glycolysis and the gut via
iruminal fermentation.

Conversion of lactate to pyruvate is

very important because lactate can not enter the TCA cycle
directly, while pyruvate can (Figure 1).
Glucose Utilization:

In both ruminants and non-ruminants, blood glucose

levels must be adequately maintained.

Bergman (1973)

estimated that only about 10% of respired CO2 was derived
from direct oxidation of glucose, however, there are at

least 6 major systems for which glucose is an obligate

requirement: the nervous system, adipose tissue

(triacylglycerol synthesis), muscle tissue, mammary tissue

(milk synthesis), the fetus and red blood cells (Bergman,
et al., 1970).

Therefore, even though glucose plays a

minor role in meeting a ruminants total energy
requirements, an adequate supply of glucose is none the
less essential.

The derivation of energy from glucose occurs in two
stages.

The first stage is referred to as the Embden-

Meyerof or glycolytic pathway and involves utilization of 2
moles of ATP to convert 1 mole of glucose into 2 moles of
glyceraldehyde-3-phosphate (Figure 2).

The 2 moles of

glyceraldehyde-3-phosphate can then be oxidized to form 2
moles pyruvate, 4 moles ATP and 2 moles NADH.

If we assume

1 mole of NADH can yield 3 moles ATP via oxidative
phosphorylation, then the conversion of 2 moles
glyceraldehyde-3-phosphate to 2 moles pyruvate could yield

a maximum of 10 moles ATP.

Subtracting the 2 moles ATP

needed to start the glycolytic pathway, there is a net

yield of 8 moles ATP per mole of glucose converted to
pyruvate.

During periods of oxygen deprivation, such as during
exercise, or relatively anaerobic conditions, such as in
the rumen, pyruvate will be converted to lactate in order

to provide NAD"*" for the conversion of glyceraldehyde-3-
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phosphate to 3-phosphoglycerol phosphate in order for the

glycolytic pathway to continue.

A net production of 2

moles of ATP is generated, therefore, by oxidation of
glucose to lactate.

The lactate generated from the breakdown of glucose
can be oxidized if it can once again be converted back to

pyruvate.

Pyruvate is converted to acetyl CoA by the

enzyme pyruvate dehydrogenase which begins the second stage
of glycolysis, the TCA cycle.

Oxidation of acetyl CoA via

the TCA cycle can yield a maximum of 15 moles of ATP
equivalents per mole of acetyl CoA oxidized.

Since one

mole of glucose can yield 2 moles acetyl CoA, a maximum of
38 moles of ATP equivalents can be generated via oxidative

degradation of glucose to CO2 and water.
Glucose and Triglyceride Synthesis:
The two major functions of glucose in adipose tissue
are the synthesis of NADPH and generation of cvglycerolphosphate for triglyceride formation.

Ruminants can not

produce fatty acids directly from glucose due to extremely
low adipose tissue activity of two key enzymes: ATP-citrate
lyase and NADP-malate dehydrogenase (Bauman, 1976).

Without ATP-citrate lyase and NADP-malate dehydrogenase the
adipocyte is unable to transfer mitochondrial acetyl CoA to
the cytosol for fatty acid synthesis.
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In the ruminant, synthesis of NADPH for fat synthesis
can occur via two metabolic pathways: the pentose
monophosphate shunt and the isocitrate cycle.

The pentose

phosphate pathway can produce 2 moles of NADPH for each
mole of glucose entering the cycle and is the major source
of NADPH for fat synthesis (Bauman, 1976).

The two

regulatory reactions in the monophosphate pathway involve
the conversion of glucose to 6-phosphoglucon-6-lactone and

6-phosphogluconate to ketogluconate-6-phosphate, which are

regulated by glucose-6-phosphate dehydrogenase and 6phosphogloconate dehydrogenase, respectively (McDonald,
1988) (Figure 3).
The isocitrate cycle produces NADPH by the conversion
of isocitrate to aketoglutarate via isocitrate

dehydrogenase.

This cycle possesses a relatively high

activity, when compared to non-ruminants, allowing
ruminants to produce a large amount of NADPH from this
cycle.

The major advantage of NADPH production via

isocitrate dehydrogenase is the glucose sparing effect.
Ruminants can produce an equal amount of NADPH for fat
synthesis utilizing less glucose than would a non-ruminant.

Nonesterified Fatty Acid Metabolism:
In the non-ruminant animal, Nonesterified fatty acids

(NEFA), or free fatty acids, provide a buffer between the
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fed and the fasted state.

Ruminant animals generally

remain in a fed state as evidenced by the amount of time
which a ruminant must be fasted before changes are seen in
blood metabolite concentrations and fluxes (Heitmann et

al., 1986)

However, NEFA's play a very important role in

the fed ruminant and an even more important role in times
of metabolic stress, such as energy restriction or
lactation (Leat, 1974).

Steinberg (1963) stated that adipose tissue

mobilization occurs primarily and almost exclusively in the
form of free fatty acids.

Net release (or uptake) of

NEFA's from adipose tissue is the result of a balance

between two opposing pathways: esterification (to form

triglycerides for storage) and hydrolysis (of stored
triglycerides) (Van Soest, 1982).
Control over NEFA mobilization is still unclear.

Bauman (1976) suggested that lipolysis is regulated via the
cyclic AMP second messenger system and hormone sensitive
lipase stimulation, however, he notes that the initial

hormone activators are still under debate.

Steingberg

(1963) listed 11 different hormonal factors which have been

shown to increase NEFA release from non-ruminant adipose
tissue.

Most of the hormones appear to increase NEFA

release by increasing triglyceride breakdown and decreasing
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triglyceride synthesis, but not shutting synthesis down
completely.
Plasma NEFA concentrations in ruminants are lower than

in non-ruminants.

This should not be surprising given that

60-80% of ruminant energy expenditure in the fed state is

provided by VFA oxidation (Blaxter, 1962).

The liver,

which is a major NEFA consumer in the ruminant will only
manufacture about 5% of NEFA's produced in the whole animal
(Van Soest, 1982).

Therefore the majority of NEFA's

reaching the liver for processing must be plasma fatty
acids derived from either the diet or from adipose tissue
brealcdown.

NEFA uptalce by the liver is concentration dependent

and has been shown to remain relatively constant (10-20%)
over a variety of conditions (Katz and Bergman, 1969b;
Heitmann, et al., 1986).

There are four major pathways

with which the liver may dispose of fatty acids: Biliary

excretion as lipoproteins, storage and secretion as

acylglycerols, complete oxidation to CO2, or incomplete
oxidation to ketone bodies.

The extent to which plasma

derived NEFA is incorporated into lipoproteins for biliary
excretion is not known.

However, Moore and Christie (1984)

estimated that 18-38% of the lipids that enter the small

intestine of a ruminant are lipids released in bile
indicating that biliary excretion and absorption could be a
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very important method of returning NEFA back to adipose
tissue.

Formation of acylglycerols can occur in the liver for

either export in association with apo-proteins or for
storage.

Emery et al. (1992) speculated that excretion

could not be an important means of removing fat from the

ruminant liver, basing their conclusions on hepatocyte
culture data.

Acylglycerol storage by the ruminant liver

is minimal and control over storage is not yet completely
understood.

For example, fatty liver, which is an

accumulation of fat in a liver beyond the level which is
normally encountered, may be the

result of a normal

physiological response (Blood and Studdert, 1988).

While NEFA biliary excretion, storage, and

acylglycerol secretion may be important means of hepatic
NEFA metabolism, the most important pathway for NEFA

disposal is oxidation.

The first step in oxidation of

fatty acids (called S-oxidation) is activation via acyl CoA
synthetase.

This occurs in the cytosol and requires two

ATP equivalents.

Carnitine is then added to the resulting

acyl-CoA by the enzyme carnitine acyl tranferase I (CAT I)
producing an acyl carnitine which can be transported into
the mitochondria, where fi-oxidation occurs.

CAT I is the

rate limiting step in the oxidation of fatty acids.
inside the mitochondria, the acyl carnitine molecule

17

Once

interacts with carnitine acyl transferase II resulting in
separation of the fatty acid CoA and the carnitine
molecules.

Oxidation of the resulting acyl CoA involves

sequential removal of two carbon units from the parent
fatty acid molecule.

Removal of the two carbon acetyl CoA

fragments results in the production of an FADH2 and NADH or
five ATP equivalents.

The acetyl CoA moiety can then be

oxidized via the TCA cycle which will yield another 24 ATP
equivalents, for a total of 29 ATP equivalents for each
acetyl CoA derived from S-oxidation of a fatty acid.
Ketone Body Metabolism:

The two major sources of ketone bodies in the ruminant

are the liver, via incomplete oxidation of plasma NEFA, and

ruminal epithelium, via oxidation of dietary substrates,

such as the volatile fatty acids acetate and, especially,
butyrate (Bergman, 1971).

In the fed animal, the

alimentary tract is the primary source of ketone bodies

(Katz and Bergman, 1969b).

The liver is capable of ketone

body production in the fed state, however, Katz and Bergman

(1969a) showed that only 0 to 30% of fatty acids taken up
by the liver, a major source of ketone body substrate, was
converted to ketone bodies.
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Hepatic uptake of free fatty acids and subsequent Soxidation within the mitochondria results in acetyl CoA
which can then be converted to acetoacetate via

hydroxymethylglutaryl (HMG) CoA (McGarry and Foster, 1980).
Acetoacetate is then converted via S-hydroxybutyrate
dehydrogenase (BHBD) to S-hydroxybutyrate (BOHB), which is

released exclusively by the liver in the fed state (Baird,
1977; Katz and Bergman, 1969).

However, BHBD in the

ruminant hepatocyte is mostly cytosolic, meaning that
acetoacetate is the only ketone body to leave the
mitochondria (Emery, et al., 1992) and subsequently, BOHB

production is subject to cytosolic NAD/NADH ratios not
mitochondrial (Koundakjian and Snoswell, 1970).
Alimentary ketogenesis occurs mainly via catabolism of
butyrate and some acetate from ruminal fermentation of the

diet (Bergman, 1971).

Since the diet provides the

substrate, portal drained viscera ketone body release may
be slowed or even stopped through fasting (Roe, et al.,
1966).

However, during fasting, the liver will increase

ketone body output which can equal or even surpass the
amount produced by the gut (Katz and Bergman, 1969b;
Heitmann, et al., 1986).

Alimentary production of ketone bodies involves
conversion of acetate and butyrate through the same
pathway, the HMG-CoA cycle.
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Acetate is converted to

acetoacetate through the addition of CoA and subsequent

metabolism via the HMG-CoA cycle of which acetoacetate is a

direct endproduct (Conn, et al., 1987).

Butyrate is

converted to Acetoacetate in rumen wall mucosa via

activation to butyryl CoA, after being absorbed from the
rumen.

Rumen mucosa possesses both butyryl CoA synthetase

and HMG-CoA synthase, the key enzymes for ketogenesis
(Baird, 1977).

As in the liver, portal production of

ketone bodies occurs almost entirely as BOHB (Katz and
Bergman, 1969).
As discussed earlier, acetoacetate and BOHB are

interconvertible via BHBD.

However, acetoacetate is not as

stable as BOHB and can spontaneously decarboxylate to form
acetone which is not utilized well by ruminant tissues

(Bergman, 1971).

Acetone itself is also unstable and quite

volatile giving rise to the odor which is sometimes
observed on the breath of untreated diabetic animals.

The

relative stability of BOHB may account for the ratio of
BOHB/acetoactetate release observed in the ruminant even

though production of BOHB from acetoacetate involves
utilization of NADH.

However, it must be noted that ketone body utilization

is mediated through metabolism of acetoacetate via succinyl
Co A transferase.

Therefore, tissues must possess BHBD in

order to utilize BOHB.

Most tissues, including skeletal
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muscle (Ruderman and Goodman, 1973), the kidneys (Baird,
1977) and the heart, can use ketone bodies and may even

"prefer" them under certain conditions, which can
contribute to the sparing of glucose. (Heitmann, et al.,
1987)

Ketone body utilization occurs via conversion of
acetoacetate to acetoacetate Co A, and subsequent splitting

by thiokinase to 2 acetyl CoA's, which can then be readily
metabolized through the TCA cycle.

Bergman (1971)

estimated that maximal whole body ketone utilization in

sheep occurs at about 20 mg/lOO ml, expressed as acetone,
and also concluded that at maximal utilization, such as in

a ketotic state, a sheep could derive approximately 20-30%

of respiratory CO2 from ketone body oxidation.
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LASALOCID

Introduction:

Lasalocid belongs to a class of compounds called

carboxylic ionophores, so named for the terminal carboxyl
group which they all possess (Painter and Pressman, 1985).

These compounds are chemically inert, except for their
ability to transport ions across biological membranes.
This feature has allowed new insight into the metabolism of

certain organs and various organelles by allowing the
researcher to perturb the delicate concentration and

electrical gradients needed by many biological systems to
function effectively.

Most recently, ionophores,

especially monensin and lasalocid, have been studied as

agricultural feed additives to improve feed efficiency in
ruminants.

lonophore Basic Properties:

Simply, ionophores facilitate movement of cations
across biological membranes and down their concentration

gradients.

In order to accomplish this feat, ionophores

must possess four basic properties (Painter and Pressman,

1985): (1) The molecule must contain both polar and nonpolar groups.

The non-polar fraction of the molecule

allows the entity to move about freely in a lipid bi-layer.
The polar fraction of the molecule allows the ionophore to
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"trap" the cation and stabilize the cation's positive

charge.

(2) The molecule must be able to assume a stable

configuration which directs its polar portions toward a
central cavity suitable for surrounding a cation.

This

conformation is usually stabilized by the formation of

intra-molecular hydrogen bonds.

The conformation must also

result in the ionophore's non-polar portion facing outward
in order for the molecule to remain lipid soluble.

The

size and electrical characteristics of the cavity formed

will determine cation preference. (3) Ion trapping and
releasing must occur at rapid rates.

A molecule which

complexes or decomplexes slowly will allow the cell time to
reestablish a concentration gradient and therefore be
ineffective. (4) The overall size and shape of the

ionophore-cation complex must allow for unrestricted
movement through the lipid bi-layer.
Lasalocid Mode of Action:

Lasalocid's ability to transport ions across
biological membranes is a function of its two structural
configurations.

The equilibrium that exists between the

two arrangements can be shifted by altering the polarity of
the solvent in which the molecule resides.

Figure 4

represents the acyclic, quasi-linear conformation of
lasalocid which is dominant in a high-polarity medium.
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Figure 5 represents lasalocid in a cyclic configuration
which is held in place by intramolecular, head-to-tail
hydrogen bond interactions.

This is the predominant form

under low polarity conditions and also allows the

ionophore-cation complex to form a stable zwitterion which
readily diffuses through biological membranes.

The arrows

in Figure 5 indicate the bonds which rotate allowing
lasalocid to quickly change conformations.
Lasalocid's mode of transport has been identified as

an electrically neutral, exchange-diffusion process,
because while cation concentration gradients are

dissipated, electrical gradients are not.

The sequence of

events occurring during ion transport by lasalocid are
shown in Figure 6.

Cation transport is initiated by a protonated
ionophore molecule diffusing toward a membrane interface.
At the interface, the proton is released, changing the

molecule's polarity and thereby trapping the molecule at
the membrane-medium interface.

to complex with a cation.

The ionophore is now able

Upon encountering a suitable

cation, the ionophore will shift to its cyclic
conformation, displacing the cation's associated water
molecule and essentially trapping the ion, forming a stable
zwitterionic complex.

This neutral compound is now able to

leave the membrane interface and diffuse to the opposite
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interface.

Once at the opposite interface, if the

situation is energetically favorable, the cation will

decomplex with the ionophore, complex with a water molecule
and enter into solution.

can occur.

At this time, one of three events

The ionophore may complex with a like cation in

what would be termed self-exchange.

This exchange does not

involve a change in the concentration gradient of the

cation.

Secondly, the ionophore may complex with a

different cation.

This event is termed exchange-diffusion

and will affect the concentration gradients of both

cations.

By this mechanism, and ionophore may dissipate

two concentration gradients simultaneously.
ionophore may assimilate a proton.

Finally, the

This option may or may

not affect the pH of either side of the membrane.

The

transport cycle may only continue if one of the above
events occurs, maintaining an electrically neutral

transport process.

Upon assimilation of a cation or

proton, the neutral ionophore may once again diffuse
through the membrane and complete the cycle.

The scheme presented above is generally accepted as
the mode of transport for lasalocid in a 1:1 complex with a
monovalent cation.

Lasalocid also possesses the ability to

transport divalent cations, such as Ca

,o

^o

and Mg

, as well.

A stable configuration is achieved by lasalocid forming a
2:1 complex with the divalent cation.
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In this 2:1 complex.

there are no new, intermolecular bonds formed between the

two ionophore molecules to hold them in position, the

configuration is held together primarily by the enclosed
cation.

Electrically neutral transport is maintained by

transport of another divalent cation or by each molecule
transporting a monovalent cation back.
The ability of lasalocid to transport both monovalent
and divalent cations must be considered in biological

situations.

Research concerning the ability of lasalocid

to transport various cations of physiological importance in
vitro has shown that the ionophore possesses a stronger

affinity for K"*" than Na"*", and Ca"^^ over Mg"*"^ (Painter and
Pressman, 1985).

No definitive data has been published

detailing lasalocid's cation preference in vivo.

However,

given that an ionophore's preference is based on the size
and electrical characteristics of the cavity formed upon

encountering a cation, one may assume that in vitro results
will translate well in vivo.

Changes in Ruminal Dynamics:

The majority of lasalocid's effects may be traced back
to the ability of the ionophore to transport cations and
dissipate concentration gradients.

Russell and Strobel

(1989) concluded that the effects of ionophore

supplementation observed in the rumen are primarily due to
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increased ion flux through microbial membranes the cation
selectively of the ionophore, the ion gradient and
microbial sensitivity.

As previously discussed, lasalocid

may transport both monovalent (e.g. K"^, Na"*") and divalent

(e.g. Ca"*"^, Mg"*"^) cations, which are sufficiently abundant
in rumen fluid (Russell and Strobel, 1989).

Concentration

gradients of ions which the ionophore will transport are
also a factor and may be more important than ionophore
selectivity.

Differing concentration gradients, along with

different pH levels, associated with different feeding
regimens may account for some of the variable responses
associated with ionophore supplementation observed in the
literature.

The mechanisms by which lasalocid alters

ruminal fermentation characteristics are due to shifts in

rumen microbial populations because of microbial
sensitivity to the ionophore (Nagaraja et al., 1987).
Initial reports on rumen microbial ionophore sensitivity in
vitro indicated that, in general, organisms that produced
succinate and fumarate were resistant to the ionophore's

antibiotic actions.

This lead Bergen and Bates (1984) to

conclude that ionophore resistance was somehow related to
the enzyme fumarate reductase.

This theory was soon

challenged by the fact that Ruminococcus flavefaciens, an
organism Icnown to produce succinate, was also sensitive to
ionophores.
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Current research suggests ionophore resistance is

related closely to cell wall structure (Chen and Wolin,
1979).

Gram-negative organisms, which tend to be

ionophore-resistant, generally possess an outer cell wall.

This outer cell wall is impermeable to many macromolecules
and solute movement is mediated by structures embedded
within the wall (Russell and Strobel, 1989).

These

structures form hydrophilic channels in the hydrophobic

outer wall. Due to the ionophore's relatively hydrophobic
structure, passage of the molecule is inhibited.

Gram-

positive organisms which lack an outer cell wall are more
likely to be sensitive to ionophore action. Ruminal
protozoa, which also lack an outer cell wall, have also

been shown to be ionophore-sensitive (Dennis et al., 1986).
Gram-positive organisms are the primary producers of
acetate, butyrate, H2, formate and ammonium.

Selection

against these organisms should result in decreased lactate
and methane production, with an increase in the molar
proportion of propionate. However, improvements in animal

production will be related to the ability of the resistant

organisms to fill the void left by the resistant organisms
(e.g. cellulose digestion) (Russell and Strobel, 1989).
Modifications of Ruminal Metabolism:
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A great number of biological responses have been
attributed to ionophore feeding.

The most widely

recognized response being the modification of ruminal
volatile fatty acid (VFA) production.

Numerous researchers

have documented a change in the acetate:propionate ratio
the rumen of ionophore-fed animals (Nagaraja et al., 1987;
Ricke et al, 1984; Van Maanen et al, 1978).

Propionate

production appears to be increased at the expense of
acetate, while total volatile fatty acid concentrations
remain constant (Armmentano and Young, 1983).

Initially,

researchers believed that increased ruminal propionate

would lead to an increased production of glucose from

propionate in the animal.

This was suggested because

Judson and Leng (1973) had demonstrated an increase in

gluconeogenesis with an intra-mesenteric propionate
infusion.

However, even though many studies demonstrate an

increase in ruminal propionate production, Harmon et.

al.(1989) found no increase in portal drained viscera (PDV)

propionate release in ionophore-supplemented animals.

This

has lead many to speculate as to the benefits of increased
ruminal propionate production.
Van Maanen (1978) speculated that the excess

propionate could either be oxidized directly to CO2, or
could contribute carbon to the synthesis of other

compounds, which would otherwise require glucose as a

35

substrate.

Harmon (1989) suggested that an increase in

ruminal propionate production may have a glucose sparing
effect on ruminal epithelium.

Decreased utilization of

glucose as an energy source may decrease the amount of
gluconeogenic substances need to maintain euglycaemia.
This phenomenon may decrease the need for amino acid use in
gluconeogenesis, which could also produce a protein-sparing
effect (Schelling, 1984).

Schelling (1984) discussed three more ways in which
increased ruminal production of propionate may be more
beneficial.

First, propionate production appears to be

more energy efficient than acetate production.

Chalupa

(1977) reported the efficiencies of fermenting hexoses to
acetate, propionate and butyrate to be 62, 109 and 78%,
respectively.

Therefore, increasing ruminal production of

propionate should increase energy retention by minimizing
fermentative losses. Second, propionate may be more
efficiently utilized by tissues than acetate (Orskov et
al., 1979).

Finally, propionate may be oxidized directly

or may be used as a substrate for gluconeogenesis, allowing
for some flexibility to respond to varying metabolic
situations.

Animals fed ionophores have also been shown to exhibit
modified feed intake and digestibility, depending on the
type of diet fed.

Feed intake depression appears to be
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greater with high grain diets than with roughage based

diets.

High grain diet ionophore supplementation generally

decreased feed intake, while body weight gains remained

steady (Delfino et al., 1988). Therefore, feed/gain ratios
were improved.

With high roughage diets, ionophore

supplementation generally did not affect feed intake, or
increased it slightly, but resulted in an increase in body
weight gain, which also improved feed/gain ratios
(Schelling, 1984).

In general, overall digestibility of a feed is
unchanged with ionophore supplementation (Spears, 1990).
Digestibility of high concentrate diets, which possess
highly fermentable carbohydrates, is not affected by

supplementation.

High fiber diets tend to show a moderate

increase in digestibility, perhaps due to an increase in
ruminal retention time (Rogers and Davis, 1982).

Spears

(1990) demonstrated that lasalocid could increase apparent

digestible energy by 2% in cattle, however, neither
monensin nor lasalocid appeared to affect digestibility in

sheep.

Delfino et al. (1988) found no change in the

digestibility of an ionophore-supplemented, high
concentrate diet fed to cattle, but reported a 10-21%

increase in the net energy for maintenance portion of the

diet.

They attributed the increased efficiency to a

decrease in fecal energy and methane losses.
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However, part

of the increase in efficiency may be due to the lower heat

increment associated with propionate metabolism (Smith,
1971).

While it is still unclear whether or not ionophores

affect true digestibility, several researchers have noted
lasalocid's ability to alter the primary site of starch

digestion (Spears, 1990; Delfino et al., 1982).
Muntifering (1981) showed a 19% decrease in apparent
ruminal starch fermentation in monensin-fed animals, with

no significant change in overall digestibility.

He

concluded that more starch was by-passing the rumen and was

being degraded in the small intestine, leading to an
increase in the proportion of energy being absorbed as

glucose.

Considered along with Orskov's (1977) observation

that absorbed glucose is used more efficiently than

absorbed propionate in the ruminant and Smith's (1971)
observation that VFA utilization may be a primary source of

wasteful heat production, increased starch digestion in the
lower GI tract could account for some of the increased

efficiency of ionophore supplementation.

However, not all

researchers have been able to demonstrate an increased PDV

glucose flux in ionophore supplemented animals (Harmon,
1989).

Methane production and loss can represent as much as

12% of feed energy intake (Russell and Strobel, 1989).
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lonophores may decrease methanogenic loss by as much as 30%
(Schelling, 1984).

The mechanism for this increased

efficiency is still unclear.

Depression of certain

microorganisms (e.g. Ruminococcus albus)

could be

responsible for a decrease in methane production.

However,

Chen and Wolin (1979) have suggested that methanogens may

not be the primary target of ionophores in the rumen.
Currently, it is believed that the decrease in methane

production is a result of decreased H2 availability,
possibly as a result of increased incorporation into
propionate (Chalupa, 1977).

Bergen and Yokoyama (1977)

also speculated that decreasing acetate production may lead
to a decrease in methanogenesis.

Even though this

depression in methane production does contribute to
conserving feed energy, the overall result is only a slight
improvement in efficiency of animal production (Schelling,
1984).
Conclusions:

lonophores contribute a great deal to improving
ruminant animal efficiency.

They accomplish this by

producing a myriad of biological effects ranging from

increased protein digestibility to earlier puberty in
heifers (Schelling, 1984).

However, at this time, all the

effects seen with ionophore-supplementation can be
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attributed to the ionophore's ability to interact with

microorganisms in the rumen.
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CHAPTER 3

EFFECTS OF ENERGY RESTRICTION ON NET
METABOLITE FLUX
ABSTRACT

Concentration and net fluxes of glucose (GLU),

nonesterifled fatty acids (NEFA), acetoacetate (ACAC), S-

hydroxybutyrate (BOHB) and volatile fatty acids (VFA) were
studied in mature, non-pregnant, non-lactating ewes.

Chronic indwelling catheters were placed in portal, hepatic
and mesenteric veins, and the caudal vena cava and aorta at

least 14 days prior to experiments.

Ewes were fed alfalfa

pellets at 100% or 50% of the NRC metabolizable energy

requirement.

On experiment days, paraaminohippurate (PAH,

1.5% @ .764 ml/min.) was infused via the mesenteric
catheter in order to measure blood flow across down stream

tissues.

After a one hour equilibration period, a series

of 6 samples (12 ml) were drawn simultaneously at 30 min.
intervals from the portal and hepatic veins and the caudal
vena cava and aorta.

Flux rates were calculated by

multiplying venoarterial (V-A) differences by blood flow
rates across the respective tissue.

Rump V-A differences

were calculated instead of flux rates because a

simultaneous blood flow could not be measured.

was analyzed for PAH, GLU, ACAC and BOHB.

analyzed for NEFA and VFA's.
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Whole blood

Plasma was

Energy restriction (ER)

reduced splanchnic blood flow specifically at the expense

of the portal vein contribution to the liver (HEP)
indicating that a larger percentage of peripherally
released metabolites reached the liver.

Energy restriction

also decreased (P<.05) arterial glucose from 2.68 to 2.41
mM due to increased (P<.05) glucose uptake by portaldrained viscera (PDV).

unchanged.

Liver GLU release (30 mmol/h) was

NEFA arterial concentrations increased (P<.01)

2 fold due to a 3 fold increase (P<.01) in rump release and

despite a 2.5 fold increase (P<.01) in hepatic uptake.

Hepatic extraction of NEFA also increased (P<.01) by 50%.
Because HEP NEFA uptake increased during ER, HEP release of
ACAC decreased (P<.01), while release of BOHB increased
(P<.05) 2 fold.

However, PDV release of both ketones

decreased -60% (P<.05, ACAC;P<.05, BOHB) due to the energy
restriction.

Arterial acetate concentration decreased

(P<.01) during ER by 36% due to a decrease (P<.01) in PDV

release of -50% (927 to 439 /xmol/min).

There was no

significant HEP flux of acetate, but rump uptake decreased
(P<.01) 43%, dependent upon concentration.

Arterial

propionate concentration was unaffected by ER despite a
decrease (P<.01) of 60% in PDV release due to a concomitant

decrease (P<.01) of 60% in HEP uptake.

Rump uptake of

propionate was not affected by ER, remaining constant at
-25-35% of circulating concentrations.
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Arterial butyrate

concentrations statistically decreased (P<.01) from 8 to 5

/xM with ER, however, this may not be physiologically
significant because both PDV release and HEP uptake
decreased (P<.01) resulting in no change in total

splanchnic output.

This work demonstrates that decreasing

ME intake by 50% increases the animals reliance on
endogenous fuels (i.e. hepatic ketogenesis and peripheral
lypolysis) because potential ME from VFA PDV release
decreased probably due to decreased organic matter
fermentation.
INTRODUCTION

An adaptive state is a stable state that is maintained
as long as the stimulus that evoked it is maintained

(Waterlow, 1986).

During periods of energy restriction, a

new plane of energy balance is attained through a reduction

in energy output and changes in intermediary metabolism
(Shetty, 1990).

The changes in body composition can be

monitored by measuring venoarterial differences and flux
rates across various tissue beds.

The laboratories of

Bergman (for review, see Bergman, 1973) and Heitmann
(Heitmann, et al., 1987; Heitmann, et al., 1986; Heitmann

and Fernandez, 1986) have used flux data to study

splanchnic tissues in fasting ewes under a variety of
conditions.
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Flux data has shovm that in ewes fasted at least 3

days, glucose arterial concentrations will fall from

approximately 50 mg/lOO ml to approximately 35 mg/100 ml
due to decreased hepatic production (Bergman, et al., 1970;
Katz and Bergman, 1969).

This change is not seen in ewes

fasted only 24 hours (Heitmann et al, 1986) indicating that
ewes must be feed deprived for at least 72 hours before

they can be considered to be in a post-absorbtive state.
Fasting will also increase circulating levels of
Nonesterified fatty acids (Bergman et al., 1970; Baird,
1977; Leat and Ford, 1966), resulting in an increase in
alterative energy sources for the liver to act upon.

Oxidation of fatty acids can result in CO2, from complete
oxidation, or the ketone bodies, Acetoacetate (ACAC) and IS-

hydroxybutyrate (BOHB), from incomplete oxidation.

During

fasting, total ketone body production will increase (Leat
and Ford, 1966).

However, this increase is due solely to a

change in liver metabolism.

Portal drained viscera release

of ketone bodies will slow or even stop, due to lack of

volatile fatty acid substrate in the rumen (Bergman and
Wolff, 1971; Roe, et al., 1966).

Liver production of both

ketones bodies will increase dramatically, however.

BOHB

release from the liver can increase as much as 5-7 fold,

while liver uptake of ACAC is changed to a net release
(Katz and Bergman, 1969; Heitmann et al., 1986).
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Fasting ruminants has helped to elicit some of the
mechanisms behind some metabolic disorders, such as

ketosis.

However, under current farming systems, it is

unlikely that a ruminant will receive no dietary substrate
for a period of 72 hours or more.

A more likely event,

short term energy restriction can result from poor

management, i.e. inadequate trough space, or from varying
environmental conditions, i.e. snow cover or low dry matter

spring pastures (Donohue and Kronfield, 1990).

Short term

energy restriction, when added to an other stressors, such
as pregnancy or lactation, can result in severe metabolic
disorders (Herdt and Emery, 1992).

The objective of this

study was to quantify the changes in metabolite
concentrations and fluxes which occur during short term

energy restriction.
MATERIALS AND METHODS

Animals and Housing:

Effects of energy restriction were studied in mature

non-pregnant, non-lactating ewes of various breeds and
crosses, weighting between 55 and 75 kg.

The animals were

housed in individual 1.8 x 3.0 m pens at approximately 17-

22 degrees Celsius.

The ewes were fed commercially

prepared alfalfa pellets daily at approximately 0800 hours.
All sheep were accustomed to being handled, therefore
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restraint was not necessary during the experimental

periods.

Water was available at all times.

Surgical Protocol:

Animals were surgically implanted with chronic indwelling
catheters placed so that the tips would reside in the

following locations: 1) caudal aorta (A), 2) caudal vena
cava (V), 3) common mesenteric vein (M), 4) hepatic vein

(H) and 5) portal vein (P), as described by Katz and

Bergman (1969) and modified by Zanzalari et al. (1989)
Briefly, the caudal aorta and vena cava catheters were

implanted by first making a 9 cm incision in the inguinal
region, just medial to the M. satorius.

The muscle layers

were then separated to expose the femoral vein and aorta.

Hepatic and portal catheters were implanted by first
making a 22 cm incision starting 4 cm caudal to the 13th
rib and 5 cm ventral to the first lumbar vertebra,

following the costal arch.

The left later lobe of the

liver was exposed, palpated, an incision was made and
catheters were inserted.

Hepatic veins were indentified

though movement of a tiny air bubble inserted into the
catheter.

Portal vein catheters were identified by

palpation of the porta hepatis.
Mesenteric vein catheters were implanted by isolating
a branch of the common mesenteric vein and inserting a
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catheter so that the tip resided in the common mesenteric
vein.

Experimental Protocol:

Animals were fed alfalfa pellets (17% Crude protein)
at either 100% or 50% of their metabolizable energy (ME)

requirement as determined by the National Research Council
(NRC) (1984) for at least ten days following surgery.
Animals which were fed 100% ME, and whose catheters

remained functional after a first experiment, were then fed
50% ME for at least ten days and a second experiment was

performed.

The ewes were weighted before being placed on

their respective diets.

Animals in the 100% ME group

maintaned their body weight.
the end of the 50% ME trials.

No measurement was made at
A total of 5 ewes were used

(three ewes had two experiments performed).

Two ewes only

had one experiment performed due to a loss of catheter
patentcy.

On experiment days, Para-aminohippurate (PAH) (Eastman
Kodak, Rochester, NY) was infused (1.5% solution @ .764

ml/min.) and allowed to equilibrate for one hour before

samples were taken.

Six serial blood samples were then

taken simultaneously from the A, H, P and V vessels at
consecutive thirty minute intervals.

Whole blood was

analyzed for glucose, PAH, acetoacetate and P-
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hydroxybutyrate.

Plasma was analyzed for nonesterifled

fatty acids (NEFA) on the day of the experiment.

Aliquots

of plasma were set aside and frozen for subsequent analysis
for volatile fatty acid (VFA) concentrations.
Analysis:

Glucose concentrations were determined utilizing a
glucose determination kit, No 510 (Sigma Chemical Co, St.

Louis, Mo.).

The exact procedure is described in Appendix

1.

Plasma NEFA concentrations were analyzed utilizing a
WAKO NEFA-C kit (WAKO Pure Chemical Industries, Osaka,

Japan). The exact procedure is described in Appendix 2.

The ketone bodies, acetoacetate and p-hydroxybutyrate,
were analyzed enzymatically based on the method of

Williamson et. al. (1962). The exact procedure is described
in Appendix 3 and 4, respectfully.
Volatile fatty acid concentrations were determined

based on the method of Reynolds et. al. (1986), with

modifications by Quigley et al (1991). The exact procedure
is described in Appendix 5.
For whole blood flow, PAH concentrations were

determined utilizing the method of Katz and Bergman (1969).
The exact procedure is described in Appendix 6.
Calculations:

51

Blood flow was determined by the indicator-dilution
method, using the following equation:

BF{l/min) = PAHp/(V-A)
PAHp represents the infusion rate of PAH in OD/min. V-A
represents the venoarterial difference in PAH concentration

for the tissue.

Portal and hepatic vein flows were

measured directly and hepatic artery contributions were

measured by hepatic-portal difference.
Flux data was determined by the following equations:
PDV (mM/min) = PF (L/min) x (P-A) (mM)
HEP (mM/min) = HF (L/min) x (H-P) (mM) +
AF (L/min) x (H-A) (mM)
TSP (mM/min) = HF (L/min) x (H-P) (mM)

PDV, HEP, and TSP represent portal drained viscera, hepatic
and total splanchnic flux, respectively.

Total splanchnic

flux is equal to PDV + HEP, however, TSP was calculated
separately.

PF, HF and AF, represent portal vein, hepatic

vein and arterial blood flow, respectively.

P, H and A

represent portal vein, hepatic vein and hepatic artery

metabolite concentrations, respectively.

Rump flux data

was not obtained because simultaneous blood flow
measurements could not be obtained.

Extraction ratios were only calculated when net fluxes

were determined to be negative and statistically different
from zero (P<.05) by the following equation:
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Extraction ratio = (net uptake / (BF x A)) x 100%

Extraction ratios represent the amount of a metabolite

presented to a tissue that is taken up by that tissue.
Statistics:

Differences between groups was tested for significance

by t-test.

Venoarterial concentration and net flux rate

differences also were determined to be different from zero

by t-test.
RESULTS

Splanchnic blood flow is shown in table 1.

Portal

vein flow decreased (P<.05) from 1.88 to 1.60 L/min during

energy restriction.

Hepatic vein blood flow tended to

decrease (P<.06) (2.35 vs. 2.08 L/min) with energy

restriction, however, the ratio of portal blood flow to

hepatic blood flow remained constant at approximately 80%.
Hepatic artery blood flow was unaffected by energy

restriction, remaining just under .50 L/min.
Glucose arterial concentrations decreased (P<.05) with

energy restriction from 2.68 to 2.41 mM (Table 2).

Portal

drained viscera flux decreased (P<.05) from a release that

was not significantly different from zero (1.57 mmol/h) at
100% ME to utilization (-8.70 mmol/h) at 50% ME.

Hepatic

release of glucose remained constant at approximately 30
mmol/h and there was no significant change in total
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Table 1

Splanchnic Blood Flow (L/min) in ewes fed at
100% and 50% of NRC requirements for ME
Portal
Vein

Hepatic

Hepatic

Vein

Artery

Portal

Hepatic

100%

1.88

2.35

0.47

0.80

50%

1.60

2.08

0.48

0.78

pSD^

0.12

0.14

0.09

0.03

.05

.06

NS

NS

P<

^pSD - Pooled Standard Deviation
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Table 2

Glucose arterial concentration (A), portal
drained viscera (PDV), hepatic (HEP) and total

splanchnic (TSP) flux rates, and rump venoarterial
differences (V-A) and extraction (RUMP Ex) in ewes
fed at 100% and 50% of NRG requirements for ME
A

PDV

HEP

TSP

V-A

RUMP

Ex

-mmol/h--

mM

mM

%

100%

2.68

1.57

30.71

32.28

-.07

2.5

50%

2.41

-8.70

29.65

20.65

-.11

5.0

pSD^

.1

4.0

5.5

5.9

.03

1.0

P<

.05

NS

NS

NS

.05

^pSD - Pooled Standard Deviation

.05

Note: Negative numbers indicate metabolite uptake
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splanchnic output.
the rump

Glucose venoarterial difference across

did not change and remained at approximately .10

mM.

Nonesterified fatty acid arterial concentrations
increased (P<.01) almost 2 fold with energy restriction

from 233 to 431 /xM (Table 3).

Portal drained viscera

release was not significantly different, however, hepatic
uptake increased (P<.01) almost 2.5 fold from 47 to 113

/xmol/h.

Hepatic extraction increased (P<.01) 50% from 12

to 18% with energy restriction.

The increase in hepatic

extraction resulted in an increase (P<.01) in total

splanchnic uptake from 32 to 84 /xmol/h.

Rump venoarterial

difference may have compensated for the increased hepatic
uptake because of increased (P<.01) fatty acid release (23
vs 77 fiM) with energy restriction.
Acetoacetate flux and concentrations are shown in
table 4.

Arterial acetoacetate concentrations increased

(P<.05) with energy restriction from 20.7 to 31.5 /xM.
Portal drained viscera release of acetoacetate decreased

(P<.05) from 30.2 to 19.3 /xmol/min with energy restriction,
however, hepatic uptake decreased (P<.01) from 32.6 to 2.0

/xmol/min resulting in an increase (P<.01) in total

splanchnic release from -2.4 to 17.3 /xmol/min.

Rump

venoarterial difference of acetoacetate was unaffected by
energy restriction.
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Table 3

Nonesterifled fatty acid arterial concentration (A),

portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flxix rates, hepatic extraction (HEP
Ex), and rump venoarterial differences (V-A) in ewes
fed at 100% and 50% of NRC requirements for ME
A

PDV

HEP

HEP

TSP

V-A

Ex

IM

--/unol/min

%

/xmol/min

(M

100%

233

is

-47

12

-32

23

50%

431

29

-113

18

-84

77

37

8

13

2

13

18

P<

.01

NS

.01

.01

.01

.01

IpSD --

Pooled Standard Deviation

pSD^

Note: Negative numbers indicate metabolite uptake
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Tcdjle 4

Acetoacetate arterial concentration (A), portal
drained viscera (PDV), hepatic (HEP) and total

splanchnic (TSP) flux rates, and rump venoarterial
differences (V-A) amd extraction (RUMP Ex) in ewes fed
at 100% and 50% of NRC requirements for ME
A

PDV

HEP

TSP

RUMP

V-A

Ex

-/miol/min-

IM

HM

%

100%

20.7

30.2

-32.6

-2.4

-5.1

12.5

50%

31.5

19.3

-2.0

17.3

-8.3

25.4

4.2

4.2

6.3

6.1

2.7

9.2

pSD^
P<

.05

.01

.05

^pSD - Pooled Standard Deviation

.01

NS

Note: Negative numbers indicate metad>olite uptake
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NS

Arterial S-hydroxybutyrate concentrations and total

splanchnic output were not significantly different between
the 100% and the 50% groups (Table 5).
a switch in the origin of the ketone.

However, there was
Portal drained

viscera release decreased (P<.05) from 269 to 170 /xmol/min,

while hepatic release increased (P<.05) almost 2 fold from
189 to 365 /xmol/min with energy restriction.

Rump

utilization was not changed with energy restriction and
remained constant at approximately 50 /xM.
Acetate arterial concentrations (Table 6) decreased

(P<.01) from 978 to 622 /xM with energy restriction, as did
portal vein concentrations (1689 vs. 1076 /xM).

Portal

drained viscera released decreased (P<.01) from 927 to 439

/xmol/h and hepatic acetate flux was not significantly
different from zero.

However, the change in portal flux

was enough to cause a decrease (P<.01) in total splanchnic

output (834 vs. 456 ^mol/h).

Rump venoarterial difference of

acetate decreased (P<.01) with enercfy restriction from 317
to 181 /xM, but this was concentration dependent, because
rump extraction ratios were not significantly different.
Propionate arterial concentrations were not different,
despite changes in splanchnic tissue flux rates (Table 7).

Portal concentrations were lower (P<.01) (215 vs. 128 /xM) .
Portal drained viscera release decreased (P<.01) from 263

to 104 /xmol/min, as did hepatic uptake (245 vs. 96
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Table 5

fi-Hydroxybutyrate arterial concentration (A),
portal drained viscera (PDV), hepatic (HEP) and
total splanchnic (TSP) flux rates, and rump

venoarterial differences (V-A) and extraction (RUMP

Ex)

in ewes fed at 100% and 50% of NRC requirements

for ME
A

HEP

PDV

TSP

V-A

RUMP
Ex

-funol/min—

/xM

HVL

%

100%

475

269

189

458

-46

9.7

50%

555

170

365

535

-50

10.8

pSD^

54

41

69

88

14

2.9

P<

NS

.05

.05

NS

NS

NS

^pSD
Note:

- Pooled Standard Deviation
Negative numbers indicate metabolite
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uptake

TaLle 6

Acetate arterial (A) and portal (P) concentrations,
portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, and rump venoarterial
differences (V-A) and extraction (RUMP EX) in ewes fed

at 100% and 50% of NRC requirements for ME
A

P

PDV

HEP

TSP

V-A

Rump
Ex

^mol/min-

IM-

fM

1

%

100%

978

1689

927

-93

834

-317

33

50%

622

1076

439

16

456

-181

25

78

113

79

67

84

37

4

.01

.01

.01

NS

.01

.01

NS

pSD^
P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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Tcdale 7

Propionate arterial (A) and portal (P) concentrations,
portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, hepatic extraction

(HEP EX) and rxunp venoarterial differences (V-A) in
ewes fed at 100% and 50% of NRC requirements for ME
A

P

PDV

HEP

HEP

TSP

V-A

Ex
itunol/min--

IM-

%

/xmol/min

/xM

100%

19

215

263

-245

82

18

-7

50%

17

128

104

-96

72

8

-5

2

19

26

24

2

4

1

NS

.01

.01

.01

.01

.05

pSD^
P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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NS

^mol/min).

Hepatic extraction also decreased (P<.01) from

82 to 72% indicating that the extraction of propionate was

not simply concentration dependent.

However, the decreases

in hepatic uptake and extraction were not enough to off-set
the decrease in portal release, resulting in a decrease

(P<.05) in total splanchnic release (18 vs. 8 /xmol/min).

Rump venoarterial difference of propionate was not changed.
Butyrate arterial (8 vs. 5 fxM) and portal (27 vs. 15
/iM) concentrations both decreased (P<.01) with energy
restriction (Table 8).

Portal drained viscera release

decreased (P<.01) almost 66% from 25 to 9 /xmol/min.

However, hepatic uptake also decreased (P<.01) almost 66%
from 21 to 6 /imol/min, resulting in no change in total
splanchnic output.

Hepatic extraction ratios were not

significantly different.

Rump venoarterial difference was

small and not significantly different from zero.

Valerate portal concentrations decreased (P<.01) from
9 to 4 /iM with energy restriction (Table 9).

Portal

drained viscera release was also lower (P<.01), decreasing

from 12 to 4 /xmol/min.

Hepatic uptake was 100% of portal

drain viscera release, and consequently decreased (P<.01)
from 12 to 4 /xmol/min.
The branched volatile fatty acids, isobutyrate (Table
10) and isovalerate (Table 11), showed no significant
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Table 8

Butyrate arterial (A) and portal concentrations,
portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, hepatic extraction (HEP
EX) and rump venoarterial differences (V-A) in ewes
fed at 100% and 50% of NRC requirements for ME
A

P

PDV

HEP

HEP

TSP

V-A

Ex

-/xmol/min-

--fM-

%

/mol/min

flM

100%

8

27

25

-21

47

4

-2

50%

5

15

9

-6

26

3

0

pSD^

1

3

4

4

12

2

1

.01

.01

.01

.01

NS

NS

NS

P<

^pSD - Pooled Standard Deviation

Note: Negative nxunbers indicate metabolite uptake
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Table 9

Valerate portal concentration (P), and portal
drained viscera (PDV) and hepatic (HEP) flux
rates in ewes fed at 100% and 50% of NRC

requirements for ME
PDV

P

HEP

funol/min100%

9

12

-12

50%

4

4

-4

pSD^

1

2

2

.01

.01

.01

P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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Table 10

Isobutyrate arterial and portal (P) concentrations,
portal drained viscera (PDV), hepatic (HEP) and
total splanchnic (TSP) flux rates, and r\imp
venoarterial differences (V-A) in ewes fed at 100%
and 50% of NRC requirements for ME
P

A

PDV

TSP

HEP

-/imol/min-

•/iM

V-A

/xM

100%

4

13

12

-13

-1

-2

50%

2

13

10

-9

1

0

pSD^

1

1

2

2

2

1

NS

NS

P<

NS

NS

^pSD - Pooled Standard Deviation

NS

NS

Note: Negative numbers indicate metabolite uptake
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TeQsle 11

Isovalerate portal concentration (P), and

portal drained viscera (PDV) and hepatic (HEP)

flux rates in ewes fed at 100% and 50% of NRC

requirements for ME
PDV

P

HEP

/mol/min-

HM
100%

11

12

-13

50%

12

11

-9

1

1

2

NS

NS

NS

pSD^
P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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change in any metabolite measured as a result of energy
restriction.
DISCUSSION

Blood Flow:

Many researchers have demonstrated that splanchnic
blood flow correlates positively with the amount of energy

consumed by the animal (Burrin, et al., 1989; Bergman and
Wolff, 1971; Mineo, et al., 1991).

The decrease in portal

and hepatic blood flows observed in this study agrees with
data from other laboratories.

While the change in hepatic

blood flow was not highly significant (P<.06), there is

previous data (Katz and Bergman, 1969) suggesting that this
decrease was real.

The fact that hepatic artery blood flow

remained the same during energy restriction, a period when
there is an increased reliance on endogenous fuels, shows
that there must be a mechanism for ensuring a constant

supply of nutrients to the liver.

This mechanism may be

controlled at the level of portal blood flow, since hepatic
artery contribution does not change.

The portal/hepatic

ratio of approximately 80% observed in this study is in
close agreement with data produced in this and other
laboratories which have demonstrated that this ratio will

remain constant under a variety of conditions, including
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pregnancy (Bergman, et al., 1970) and fasting (Bergman and
Wolff, 1971; Heitmann et al., 1986).
Glucose Metabolism:

The decrease in glucose arterial concentration
observed in this study is consistent with decreases

observed in other laboratories in feed restricted animals

(for review, see Baird, 1977). Because hepatic production

of glucose did not decrease, increased portal drained
visceral glucose consumption could have explained some of
the decrease in arterial concentration.

However, some

other tissues may have changed their individual glucose
metabolism as well.

One organ in particular, the kidney,

which may be responsible for up to 15% of glucose

production in the ruminant (Bergman, 1973), may have
decreased glucose production.

The majority of

gluconeogenic substrates absorbed by the gut must first
pass through the liver. Since liver production of glucose
was not affected by energy restriction, a time when there

is less exogenous fuel available to the liver, an increased
reliance on endogenous substrates may have limited

gluconeogenic precursor availability to the kidneys.
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Free Fatty Acid and Ketone Body Metabolism:
Increased arterial concentrations are a generally

recognized response to restrictions in energy intake (Emery
et al., 1992; Sheety, 1990; Leat and Ford, 1966).
Therefore, the 2 fold increase observed in this study would

be considered a normal response.

This increased arterial

concentration appears to be a result of increased rump

release, since portal drained viscera release did not

change.

It should be remember that portal drained viscera

nonesterified fatty acid release represents omental

lypolysis because absorbed fat is released via the lymph
system to the venous blood at the thoracic duct.
Increased hepatic uptake was not due solely to the
increase in circulating concentrations, as evidenced by the
increase in the hepatic extraction ratio.

The 50% increase

in the extraction ratio indicates that a mechanism may be

involved which attempts to maintain an adequate supply of
energy to the liver, in spite of decreased exogenous
substrate and blood flow. Whatever the mechanism, the liver

did increase free fatty acid uptake during energy

restriction greater than 2 fold, which accounted for all
the of the increase in total splanchnic uptake.

Increased free fatty acid uptake by the liver has been
associated with an increase in ketone body concentrations
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(Emery et al., 1992).

Bergman (1971) showed that ketone

body release during energy restriction ketosis was a result
of over production by the liver, not under utilization by
extra-hepatic tissues.

In the present study, arterial

concentrations of acetoacetate did increase.

The main

reason for this increase appears to be a lack of uptake by

the liver.

Total splanchnic output increase 33%, in spite

of a significant decrease in portal drained viscera
release, because of lack of acetoacetate uptake by the
liver

This laboratory and others have demonstrated a change
in liver acetoacetate metabolism during energy restriction.

Most researchers report a change from liver uptake to liver
release after a three day fast (Roe et al, 1966; Katz and

Bergman, 1969; Heitmann, et al., 1989).
not seen in the current experiment.

This change was

The assumption can

then be made that animals fed at 50% of their requirements
would not fall into a ketotic state.

However, since

arterial concentrations were elevated, it appears that the

animal's ability to utilize ketone bodies had already
reached a maximum.

While these animals appeared healthy,

even during the energy restriction periods, it appears that
ewes which remain at 50% ME for extended periods may

develop signs of ketosis.
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S-hydroxybutyrate arterial concentrations did not rise
with energy restriction, probably because total splanchnic
release did not change.
of the ketone body.

There was a change in the source

Portal drained viscera release

decreased probably due to the decrease in available
substrate from the rumen.

Hepatic production increased,

possibly due to the increased fatty acid uptake.
Volatile Fatty Acid Metabolism:

All of the major volatile fatty acids - acetate,

propionate and butyrate - demonstrated a decrease in portal
concentration with energy restriction.
metabolism of each fatty acid varied.

However, splanchnic
Acetate arterial

concentration decreased 36% despite a 42% decrease in rump

utilization.

the rump venoarterial difference was passive

and concentration dependent, since extraction ratios did
not change.

The majority of the arterial concentration

change was probably due to a 45% decrease in total
splanchnic release.

The decrease in splanchnic release was

a result of decreased portal drained viscera release, as

hepatic flux was not significantly different between
treatments.

These results are consistent with previously

published data (Bergman and Wolff, 1971).
Portal drained viscera release of propionate decreased

approximately 60% with energy restriction.
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Hepatic uptake

also decreased by the same percentage, but not enough to
maintain total splanchnic output, which decreased

significantly.

This is similar to data produced by Bergman

et al. (1966), also in 50 % feed restricted animals

The

decrease in hepatic propionate uptake was not simply
concentration dependent, as there was also a significant

drop in the hepatic extraction ratio.

Arterial propionate

concentrations did not decrease, however, possibly due to

an increase in ketone body utilization by tissues which

possess the capability to use both ketone bodies and short
chain fatty acids.

There was no change in total splanchnic butyrate
release.

This occurred because the decrease in hepatic

uptake paralleled the decrease in portal drained viscera
release, which has been demonstrated earlier by Bergman and
Wolff (1971).

However, there was an unexpected decrease in

arterial concentration.

Since rump venoarterial

differences and total splanchnic release were not different

from zero, it is possible that some other tissues, such as

the kidney cortex (Pennington, 1951), began using butyrate
due to the decrease in substrates which occurred with the

change in energy balance.

Valerate portal concentrations decreased

significantly, as did portal flux.

Hepatic uptake also

decreased, however, this may have been a direct result of
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the decrease in portal release.

Since little or no

arterial valerate was present, it is difficult to state

whether or not the liver possesses the ability to utilize
greater quantities of valerate.
The branched-chain volatile fatty acids, isobutyrate

and isovalerate, showed no significant change in flux rates
or concentrations.

However, since the concentrations of

these acids are so low, they were not considered to be of
major physiological importance.
CONCLUSION

As expected, a 50% restriction in energy intake
decreased the energy released by the portal drained viscera
almost 50% (Table 12).

However, only a fraction of the

energy fed to the animals appeared in the portal vein as
metabolites measured in this study.

Other sources of

energy, such as nonesterified fatty acids and amino acids,
released from the gut were not measured and may have

counted for a large portion of the ingested energy.

Also

not measured were losses due to methane production and the
undigestible portion of the feed.
Table 12 illustrates that while a 60% decrease in the

major volatile fatty acids occurred, ketone body release
only decreased approximately 35%.

Therefore, rumen

epithelium maintained its ketogenic capacity, converting

74

approximately 90% of the available butyrate to ketone
bodies.
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Table 12

Energy release as VFA or ketone bodies from portal
drained viscera of sheep fed at 50 or 100% of
NRC requirements for ME
100%

Acetate

Propionate
Butyrate

Isobutyrate
Valerate
Isovalerate

S-Hydroxybutyrate
Acetoacetate

Total

1167
578

50%

553
229

%Decrease

53
60

28

65
18

49
790
78

31
16
45
499
50

37

2828

1451

48

79
38
49

76

67

8
36
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CHAPTER 4

EFFECTS OF ENERGY RESTRICTION AND LASALOCID
ON NET METABOLITE FLUX
ABSTRACT

Concentration and net fluxes of glucose (GLU),

nonesterifled fatty acids (NEFA), acetoacetate (ACAC), B-

hydroxybutyrate (BOHB) and volatile fatty acids (VFA) were
studied in mature, non-pregnant, non-lactating ewes.

Chronic indwelling catheters were placed in portal, hepatic
and mesenteric veins, and the caudal vena cava and aorta at

least 14 days prior to experiments.

Ewes were fed alfalfa

pellets at 100% or 50% of the NRC metabolizable energy
requirement with the addition of the ionophore lasalocid.
On experiment days, paraaminohippurate (PAH, 1.5% @ .764
ml/min.) was infused via the mesenteric catheter in order
to measure blood flow across down stream tissues.

After a

one hour equilibration period, a series of 6 samples (12
ml) were drawn simultaneously at 30 min. intervals from the
portal and hepatic veins and the caudal vena cava and
aorta.

Flux rates were calculated by multiplying

venoarterial (V-A) differences by blood flow rates across

the respective tissue.

Rump V-A differences were

calculated instead of flux rates because a simultaneous

blood flow could not be measured.
for PAH, GLU, ACAC and BOHB.
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Whole blood was analyzed

Plasma was analyzed for NEFA

and VFA's.

Energy restriction (ER) did not change

splanchnic blood flow. Arterial glucose concentration
actually increased (P<.01) from 2.36 to 2.56 mM despite a
decease (P<.05) in total splanchnic (TSP) release of 40%.
Liver (HEP) release of GLU was not statistically different,

however, it was approx. 33% lower than what was expected
(20 vs. 30 mmol/h).

NEFA arterial concentrations increased

(P<.01) 2 fold despite a 2 fold increase (P<.01) in hepatic

uptake and a switch from rump release to utilization
(P<.01).

Arterial ACAC concentrations did not change

despite a decrease (P<.01) of 60% in portal vein viscera
(PDV) release.

BOHB arterial concentrations increased

(P<.01) due to an increase (P<.01) in HEP production of
45%.

Acetate arterial concentrations decreased (P<.01), as

did portal concentrations.

PDV acetate release decreased

(P<.01) almost 65%, resulting in decreased (P<.01) TSP

release.

Propionate arterial concentrations decreased

(P<.01) almost 50%, while portal concentrations decreased
(P<.01) almost 65%.
almost 4 fold.

fold.

PDV release of propionate decreased

HEP propionate uptake decreased nearly 3.5

However, TSP release still saw a decrease (P<.01)

from 31 to 2 /imol/min.

Butyrate arterial concentrations

decreased (P<.01), as did portal concentrations.

There was

no change in TSP butyrate release, despite a decrease
(P<.01) of 65% in PDV release.
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HEP butyrate uptake also

decreased (P<.01) 3 fold.

decreased (P<.05) 40%.

Valerate portal concentrations

PDV release of valerate decreased

(P<.05) 40%, as did HEP uptake.

There were no significant

net flux changes with either of the branched chain volatile
fatty acids, isobutyrate and isovalerate.
INTRODUCTION

Lasalocid belongs to a class of compounds called

carboxylic ionophores, so named for the terminal carboxyl

group which they all possess (Painter and Pressman, 1985).
These compounds are chemically inert, except for their
ability to transport ions across biological membranes.
This feature has allowed new insight into the metabolism of

certain organs and various organelles by allowing the
researcher to perturb the delicate concentration and
electrical gradients needed by many biological systems to
function effectively.

Most recently, ionophores,

especially monensin and lasalocid, have been studied as

agricultural feed additives to improve feed efficiency in
ruminants.

The majority of lasalocid's effects may be traced back
to the ability of the ionophore to transport cations and
dissipate concentration gradients.

Russell and Strobel

(1989) concluded that the effects of ionophore

supplementation observed in the rumen are primarily due to
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increased ion flux through microbial membranes, the cation

selectively of the ionophore, ion gradients and microbial
sensitivity.

Lasalocid may transport both monovalent (e.g.

K"^, Na"*") and divalent (e.g. Ca'^^, Mg^^) cations, which are
sufficiently abundant in rumen fluid (Russell and Strobel,
1989).

Concentration gradients of ions which the ionophore

will transport are also a factor and may be more important

than ionophore selectivity.

Differing concentration

gradients, along with different pH levels, associated with
different feeding regimens may account for some of the
variable responses associated with ionophore

supplementation observed in the literature.

The mechanisms

by which lasalocid alters ruminal fermentation
characteristics are due to shifts in rumen microbial

populations because of microbial sensitivity to the
ionophore (Nagaraja et al., 1987).
Current research suggests ionophore resistance is

related closely to cell wall structure (Chen and Wolin,
1979).

Gram-negative organisms, which tend to be

ionophore-resistant, generally possess an outer cell wall.
Gram-positive organisms which lack an outer cell wall are
more likely to be sensitive to ionophore action.

Ruminal

protozoa, which also lack an outer cell wall, have also
been shown to be ionophore-sensitive (Dennis et al., 1986).
Gram-positive organisms are the primary producers of
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acetate, butyrate, H2, formate and ammonium.

Selection

against these organisms should result in decreased lactate
and methane production, with an increase in the molar

proportion of propionate.

However, improvements in animal

production will be related to the ability of the resistant
organisms to fill the void left by the resistant organisms
(e.g. cellulose digestion) (Russell and Strobel, 1989).
A great number of biological responses have been
attributed to ionophore feeding.

The most widely

recognized response being the modification of ruminal
volatile fatty acid (VFA) production.

Numerous researchers

have documented a change in the acetate:propionate ratio in
the rumen of ionophore-fed animals (Nagaraja et al., 1987;
Ricke et al, 1984; Van Maanen et al, 1978).

Propionate

production appears to be increased at the expense of
acetate, while total volatile fatty acid concentrations

remain constant (Armstrong and Young, 1983).

Initially,

researchers believed that increased ruminal propionate
would lead to an increased production of glucose from

propionate in the animal.

This was suggested because

Judson and Leng (1973) had demonstrated an increase in
gluconeogenesis with an intra-mesenteric propionate
infusion.

However, even though many studies demonstrate an

increase in ruminal propionate production, Harmon et.

al.(1989) found no increase in portal drained viscera (PDV)
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propionate release in ionophore-suppleinented animals.
Animals fed ionophores have also been shown to exhibit
modified feed intake and digestibility, depending on the

type of diet fed.

While it is still unclear whether

ionophores affect true digestibility, several researchers
have noted lasalocid's ability to alter the primary site of

starch digestion (Spears, 1990; Delfino et al., 1982).

Ionophores may also decrease methanogenic loss by as much
as 30% (Schelling, 1984).

All the effects seen with ionophore supplementation

can be attributed to the ionophore's ability to interact

with microorganisms in the rumen.

These interactions in

the rumen will cause changes in metabolite release from the

portal drained viscera.

However, in all the experimental

data generated to date rumen, microbes have been in a state
of positive energy balance.

The objective of the study was

to determine the effects of ionophore supplementation on
metabolite concentrations and fluxes in splanchnic tissues

during short term energy restriction.
MATERIALS AND METHODS

Animals and Housing:

Effects of energy restriction were studied in mature

non-pregnant, non-lactating ewes of various breeds and
crosses, weighing between 55 and 75 kg.
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The animals were

housed in individual 1.8 x 3.0 m pens at approximately 17-

22 degrees Celsius.

The ewes were fed commercially

prepared alfalfa pellets daily at approximately 0800 hours.
All sheep were accustomed to being handled, therefore
restraint was not necessary during the experimental

periods.

Water was available at all times.

Surgical Protocol:

Animals were surgically implanted with chronic indwelling

catheters placed so that the tips would reside in the
following locations: 1) caudal aorta (A), 2) caudal vena
cava (V), 3) common mesenteric vein (M), 4) hepatic vein
(H) and 5) portal vein (P), as described by Katz and

Bergman (1969) and modified by Zanzalari et al. (1989)
Briefly, the caudal aorta and vena cava catheters were

implanted by making a 9 cm incision in the inguinal region,
just medial to the M. satorius.

The muscle layers were

then separated to expose the femoral vein and aorta.
Hepatic and portal catheters were implanted by first

making a 22 cm incision starting 4 cm caudal to the 13th
rib and 5 cm ventral to the first lumbar vertebra,

following the costal arch.

The left lateral lobe of the

liver was exposed, palpated, an incision was made and
catheters were inserted.

Hepatic veins were indentified

though movement of a tiny air bubble inserted into the
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catheter.

Portal vein catheters were identified by

palpation of the porta hepatis.
Mesenteric vein catheters were implanted by isolating
a branch of the common mesenteric vein and inserting a

catheter so that the tip resided in the common mesenteric
vein.

Experimental Protocol:

Animals were fed alfalfa pellets (17% protein) at
either 100% or 50% of their metabolizable energy (ME)

requirement as determined by the National Research Council
(NEC) (1984) plus Lasalocid (Bovatec 20 Liquid, HoffmanLaRoche, Inc., Nutley, NJ) for at least ten days following
surgery.

Animals which were fed 100% ME, and whose

catheters remained functional after a first experiment,
were then fed 50% ME for at least ten days and a second

experiment was performed.

The ewes were weighted before

being placed on their respective diets.

Animals in the

100% ME group maintaned their body weight.
was made at the end of the 50% ME trials.

No measurement
A total of 5

ewes were used (three ewes had two experiments performed).

Two ewes only had one experiment performed due to a loss of
catheter patentcy.

On experiment days, Para-aminohippurate (PAH) (Eastman
Kodak, Rochester, NY) was infused (1.5% solution @ .764
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ml/min.) and allowed to equilibrate for one hour before

samples were taken.

Six serial blood samples were then

taken simultaneously from the A, H, P and V vessels at

consecutive thirty minute intervals.

Whole blood was

analyzed for glucose, PAH, acetoacetate and Phydroxybutyrate.

Plasma was analyzed for nonesterified

fatty acids (NEFA) on the day of the experiment.

Aliquots

of plasma were set aside and frozen for subsequent analysis
for volatile fatty acid (VFA) concentrations.
Analysis:
Glucose concentrations were determined utilizing a

glucose determination kit. No 510 (Sigma Chemical Co, St.
Louis, Mo.).

The exact procedure is described in Appendix

1.

Plasma NEFA concentrations were analyzed utilizing a
WAKO NEFA-C kit (WAKO Pure Chemical Industries, Osaka,

Japan). The exact procedure is described in Appendix 2.
The ketone bodies, acetoacetate and p-hydroxybutyrate,

were analyzed enzymatically based on the method of
Williamson et. al. (1962). The exact procedure is described
in Appendix 3 and 4, respectfully.

Volatile fatty acid concentrations were determined
based on the method of Reynolds et. al. (1986), with

modifications by Quigley et al (1991). The exact procedure
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is described in Appendix 5.

VFA determination was only

performed on the 100% ME group due to loss of plasma
samples.
For whole blood flow, PAH concentrations were

determined utilizing the method of Katz and Bergman (1969).
The exact procedure is described in Appendix 6.
Due to a loss of catheter patentcy, rump data was

obtained on only two animals in the 50% ME group.
Calculations:

Blood flow was determined by the indicator-dilution
method, using the following equation:

BF(l/min) = PAHp/(V-A)

PAHp represents the infusion rate of PAH in OD/min. V-A
represents the venoarterial difference in PAH concentration
for the tissue.

Portal and hepatic vein flows were

measured directly and hepatic artery contributions were
measured by hepatic-portal difference.
Flux data was determined by the following equations:
PDV (mM/min) = PF (L/min) x (P-A) (mM)
HEP (mM/min) = HF (L/min) x (H-P) (mM) +
AF (L/min) x (H-A) (mM)
TSP (mM/min) = HF (L/min) x (H-P) (mM)

PDV, HEP, and TSP represent portal drained viscera, hepatic

and total splanchnic flux, respectively.

Total splanchnic

flux is equal to PDV + HEP, however, TSP was calculated
separately.

PF, HF and AF, represent portal vein, hepatic
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vein and arterial blood flow, respectively.

P, H and A

represent portal vein, hepatic vein and hepatic artery
metabolite concentrations, respectively.

Rump flux data

was not obtained because simultaneous blood flow
measurements could not be obtained.

Extraction ratios were only calculated when net fluxes

were determined to be negative and statistically different

from zero (P<.05) by the following equation:
Extraction ratio = (net uptake / (BF x A)) x 100%
Extraction ratios represent the amount of a metabolite

presented to a tissue that is taken up by that tissue.
Statistics:

Differences between groups was tested for significance

by t-test.

Venoarterial concentration and net flux rate

differences also were determined to be different from zero

by t-test.
RESULTS

Splanchnic blood flow is shown in table 1.

Portal

vein flow did not decrease during energy restriction,

remaining constant at approximately 1.80 L/min.
vein blood flow was also unchanged.

Hepatic

The ratio of portal

blood flow to hepatic blood flow remained constant at
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Table 1

Splanchnic Blood Flow (L/min) in ewes fed at 100%

and 50% of NRC requirements for ME plus ionophore
Portal
Vein

Hepatic

Hepatic

Vein

Artery

Portal

Hepatic

100%

1.91

2.41

0.50

0.81

50%

1.78

2.17

0.39

0.83

pSD^

0.12

0.18

0.09

0.03

NS

NS

NS

NS

P<

^pSD - Pooled Standard Deviation
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approximately 82%.

Hepatic artery blood flow did not

change significantly with energy restriction.
Paradoxically, glucose arterial concentrations
increased (P<.05) with energy restriction from 2.36 to 2.54

mM (Table 2).

Portal drained viscera and hepatic glucose

fluxes were not significantly different, however total

splanchnic output was statistically lower (P<.05) in the

energy restricted animals (22.27 vs. 17.63 mmol/h). Rump
glucose venoarterial difference did not change and was
approximately 1.0 mM.

Nonesterified fatty acid arterial concentrations
increased (P<.01) almost 2 fold with energy restriction

from 179 to 366 /xM (Table 3).

Portal drained viscera

release was not significantly different, however, hepatic
uptake increased (P<.01) almost 2 fold from 42 to 95

;imol/h.

The increase in hepatic uptake resulted in an

increase (P<.01) in total splanchnic uptake from 22 to 54

/imol/h.

Rump fatty acid release decreased (P<.01),

changing from a net release (9 /xM) in 100% animals, to a
net uptake (10 /xM) in fed restricted animals.
Acetoacetate flux and concentrations are shown in
table 4.

Arterial acetoacetate concentrations were not

changed with energy restriction remaining around 30 /xM.
Portal drained viscera release of acetoacetate decreased
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Table 2

Glucose arterial concentration (A), portal drained

viscera (PDV), hepatic (HEP) and total splanchnic

(TSP) flux rates, and rump venoarterial differences
(V-A) and extraction (RUMP Ex) in ewes fed 100% and
50% of NRC requirements for ME plus ionophore
A

HEP

PDV

TSP

V-A

RUMP

Ex
mM

xnM

%

100%

2.36

-1.44

23.71

22.27

-0.07

2.92

50%

2.54

-4.44

17.63

13.20

-0.03

1.34

pSD^

.09

2.38

3.84

3.41

.84

2.09

P<

.05

NS

^pSD -

NS

.05

NS

Pooled Standard Deviation

Note; Negative numbers indicate metadjolite uptake
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Table 3

Nonesterifled fatty acid arterial concentration (A),

portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, hepatic (HEP Ex)

extraction, and rump venoarterial differences (V-A)
in ewes fed 100% and 50% of NRC requirements
for ME plus ionophore
A

HEP

PDV

HEP

TSP

V-A

Ex

yM

- -funol/h-

%

/nnol/h

fiM

100%

179

19

-42

-11.9

-22

9

50%

366

41

-95

-14.5

-54

-10

34

12

17

2.1

10

6

.01

NS

.01

.01

.01

pSD^
P<

NS

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metcibolite uptake
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Table 4

Acetoacetate arterial concentration (A), portal

drained viscera (PDV), hepatic (HEP) and total

splanchnic (TSP) flux rates, and rump venoarterial
differences (V-A) and extraction (RUMP Ex) in ewes

fed at 100% and 50% of NRC requirements for ME plus
ionophore
A

HEP

PDV

TSP

V-A

RUMP
Ex

-funol/min--

(M

fM

%

100%

35.8

64.5

-25.1

39.3

-10.4

20.2

50%

28.3

23.9

-12.7

11.2

-17.0

43.7

pSD^

4.6

10.4

17.1

19.0

8.5

25.7

P<

NS

NS

NS

.01

^pSD - Pooled Standard Deviation

NS

Note: Negative niimbers indicate meted>olite uptake
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NS

(P<.01) from 64.5 to 23.9 ^mol/min with energy restriction,

however, hepatic uptake and total splanchnic output were
unaffected by energy restriction.

Rump uptake of

acetoacetate was not changed by energy restriction.

Arterial S-hydroxybutyrate concentrations increased
(P<.01) during energy restriction from 391 to 581 fiM (Table
5).

Portal drained viscera release was unchanged, while

hepatic release increased (P<.01) almost 2 fold from 218 to

399 ^mol/min with energy restriction.

As a result, total

splanchnic output increased (P<.05) from 421 to 564

/xmol/min.

Rump utilization was not changed with energy

restriction and remained constant at approximately 60 /xM.
Acetate arterial concentrations (Table 6) decreased

(P<.01) from 1067 to 515

with energy restriction, as did

portal vein concentrations (2115 vs. 989 /xM) .

Portal

drained viscera release decreased (P<.01) from 1410 to 515

/xmol/min, but hepatic acetate flux was highly variable and
not significantly different from zero.

However, the change

in portal flux was enough to cause a decrease (P<.01) in

total splanchnic output (1428 vs. 362 /xmol/min).
Propionate arterial concentrations decreased (P<.01)
from 28 to 16 /xM (Table 7).

Portal concentrations were

also lower (P<.01) (321 vs. 113 /xM).

Portal drained

viscera release decreased (P<.01) from 394 to 102 /xmol/min.
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Tcdsle 5

S-Hydroxybutyrate arterial concentration (A), portal
drained viscera (PDV), hepatic (HEP) and total

splanchnic (TSP) flux rates, and rump venoarterial

differences (V-A) and extraction (RUMP Ex) in ewes fed
at 100% and 50% of NRC requirements for ME plus
ionophore
A

PDV

HEP

TSP

V-A

RUMP
Ex

-funol/min- -

fiM

%

100%

391

203

218

421

-73

20.3

50%

581

165

399

564

-53

11.0

42

41

60

63

26

7.0

.01

NS

.01

.05

NS

NS

pSD^
P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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Table 6

Acetate arterial (A) and portal (P) concentrations,

portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, and rump venoarterial
differences (V-A) and extraction (RUMP EX) in ewes fed

100% and 50% of NRC requirements for ME plus ionophore
A

P

PDV

HEP

TSP

V-A

Rump
Ex

filA
100%

/xmol/min

/xM

1067

2115

1410

19

1428

50%

515

989

515

-153

362

pSD^

140

347

301

134

347

P<

.01

.01

.01

NS

.01

^pSD - Pooled Standard Deviation

-391

Note: Negative numbers indicate metabolite uptake

100

%
37.9

TeQjle 7

Propionate arterial (A) and portal (P) concentrations,
portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, hepatic extraction
(HEP Ex) and rump venoarterial differences (V-A) in

ewes fed 100% and 50% of NEC requirements for ME plus

ionophore
P

A

HEP

PDV

HEP

TSP

V-A

Ex

fiM-

--/imol/min--

%

^ol/min

/xM
-7

100%

28

321

394

-363

80

31

50%

16

113

102

-100

76

2

4

58

71

66

3

8

.01

.01

.01

.01

NS

.01

pSD^
P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate meteJsolite uptake
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as did hepatic uptake (363 vs. 100 /xmol/min).

However

decrease in hepatic uptake was not enough to off-set the

decrease in portal release, resulting in a decrease (P<.01)
in total splanchnic release (31 vs. 2 /xmol/min).
Butyrate arterial (7 vs. 2 fiM) and portal (32 vs. 11
fiM) concentrations both decreased (P<.01) with energy
restriction (Table 8).

Portal drained viscera release

decreased (P<.01) 65% from 34 to 12 /xmol/min.

However,

hepatic uptake also decreased (P<.01) 70% from 27 to 8
/xmol/min, resulting in no change in total splanchnic
output.

Isobutyrate arterial and portal concentrations were
both unchanged by energy restriction (Table 9).

Portal

drained viscera release of isobutyrate was lowered (P<.01)

from 23 to 10 /xmol/min.

Hepatic uptake was not

significantly different.
Valerate portal concentrations decreased (P<.05) from
10 to 6 /iM with energy restriction (Table 10).

Portal

drained viscera release was also lower (P<.05), decreasing

from 14 to 8 ^mol/min.

However, hepatic uptake mirrored

portal drain viscera release, as uptake decreased (P<.01)

from 14 to 8 /imol/min.
Isovalerate portal concentrations were not

significantly different, however portal drained viscera

flux were lower (P<.01), decreasing from 22 to 11 ^mol/min
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Table 8

Butyrate arterial (A) and portal (P) concentrations,
portal drained viscera (PDV), hepatic (HEP) and total
splanchnic (TSP) flux rates, hepatic extraction (HEP
Ex) and rump venoarterial differences (V-A) in ewes
fed 100% and 50% of NRC requirements for ME plus
ionophore
A

P

PDV

HEP

HEP

TSP

V-A

Ex

-/imol/min-

-IM.

%

/xmol/min

100%

7

32

34

-27

54

7

50%

2

11

12

-8

56

3

pSD^

1

5

7

6

9

2

.01

.01

.01

.01

NS

NS

P<

^pSD - Pooled Standard Deviation

Note: Negative ntnnbers indicate metedjolite uptake
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fM
-2

Table 9

Isobutyrate arterial (A) and portal (P)
concentrations, portal drained viscera (PDV), hepatic

(HEP) and total splanchnic (TSP) flux rates, and rxunp
venoarterial differences (V-A) in ewes fed 100% and

50% of NRC requirements for ME plus ionophore
A

P

PDV

HEP

TSP

--/unol/min-

IM-

fOi

100%

5

22

23

-21

2

50%

6

15

10

-13

-3

pSD^

1

4

4

4

2

NS

NS

.01

NS

.05

P<

^pSD - Pooled Standard Deviation

V-A

-1

Note; Negative nvunbers indicate metabolite uptake
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TeQ}le 10

Valerate portal concentration (P), and portal

drained viscera (PDV) and hepatic (HEP) flux
rates in ewes fed at 100% and 50% of NRC

requirements for ME plus ionophore
PDV

P

HEP

fmol/min-

HK
10

14

-14

50%

6

8

-8

pSD^

2

2

2

.05

.05

.05

100%

P<

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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o

ni

•

Table 11

Isovalerate portal concentration (P), and

portal drained viscera (PDV) and hepatic (HEP)

flux rates in ewes fed at 100% and 50% of NRC

requirements for ME plus ionophore
PDV

P

HEP

/unol/min
100%

19

22

-20

50%

14

11

-11

3

4

pSD^
P<

3
•

NS

o

H

^pSD - Pooled Standard Deviation

Note: Negative numbers indicate metabolite uptake
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during energy restriction (Table 11). However, hepatic

uptake mirrored portal drain viscera release, as uptake
decreased (P<.01) from 20 to 11 /xmol/min.
DISCUSSION

Blood Flow:

Many researchers have demonstrated that splanchnic
blood flow varies with the amount of energy consumed by the
animal (Burrin, et al,, 1989; Bergman and Wolff, 1971;

Mineo, et al., 1991).

The study immediately previous and

presented above also showed decreased portal and hepatic
vein blood flow

However, in this study although the actual

rates were extremely similar to the study above, there were

no significant changes in splanchnic blood flow between the
energy restricted and full-fed animals due to slightly
higher variability.

The portal/hepatic ratio of

approximately 80% observed in this study is in close

agreement with data produced in this and other laboratories
which have demonstrated that this ratio will remain

constant under a variety of conditions, including pregnancy

(Bergman, et al., 1970) and fasting (Bergman and Wolff,
1971; Heitmann et al., 1986).
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Glucose Metabolism:

Glucose arterial concentrations actually rose in the

energy restricted animals.

This result conflicts with the

decrease in arterial concentrations seen in non-

supplemented energy restricted animals (see Baird, 1977 and
the above study).

In previous work with energy restricted

animals reported above, hepatic glucose production remained
similar in both 100% and 50% fed animals.

Hepatic

production in this study also remained similar between

groups, but, it was approximately two thirds of the rate of
the non-supplemented animals (20 vs. 30 mmol/h).

However,

Harmon et al. (1993) reported no change in hepatic glucose
release in steers supplemented with monensin.

Therefore,

hepatic production could not explain the rise in arterial
glucose concentrations.

Portal drained viscera uptake was

not significantly different from zero.

This was different

from the significant net uptake which occurred in non-

supplemented energy restricted animals in the previous

study, and data generated from ionophore treated animals in
studies by

Harmon and co-workers (Harmon et al., 1993;

Harmon et al. 1989; Harmon and Avery, 1987).

The previous

energy restriction study showed an increase in portal
drained viscera glucose uptake concomitant with the
decrease in arterial concentrations.
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Paradoxically, total

splanchnic release of glucose decreased (P<.05) making
interpretation of the observed increase in glucose
difficult, unless there was a concomitant and greater

decrease in glucose utilization by other tissues.

Rump

venoarterial difference decreased numerically, but not
significantly.

Free Fatty Acid and Ketone Body Metabolism:
Increased concentrations of circulating free fatty

acids are a generally recognized response to restrictions
in energy intake (Emery et al., 1992; Sheety, 1990; Leat
and Ford, 1966).

this response.

Lasalocid supplementation did not change

There was no change in portal drained

viscera release, but hepatic uptake increased, resulting in
a decrease in total splanchnic release.

Since peripheral

lypolysis as measured by rump venoarterial difference in
this study is considered to be the major supplier of free

fatty acids during energy restriction, the reason for the
increase in arterial free fatty acid is unclear.

Increased free fatty acid uptake by the liver has been
associated with an increase in ketone body concentrations

(Emery et al., 1992).

Bergman (1971) showed that ketone

body release during energy restriction ketosis was a result
of over production by the liver, not under utilization by
extra-hepatic tissues.

However, with lasalocid
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supplementation, there was no significant change in hepatic
acetoacetate uptake.

Total splanchnic acetoacetate release

was not statistically different, with energy restriction,
despite a 66% decrease in portal drained viscera release
due to variability.

Energy restricted non-supplemented

animals, in the above study, did have a decrease in both

total splanchnic and hepatic release, which probably caused
the decrease in arterial concentrations observed in that

study.

Lasalocid supplemented animals did not have a

decreased arterial acetoacetate concentration during energy

restriction.

One possible explanation for this may have

been that lasalocid fed animals had numerically higher

portal drained viscera acetoacetate release rates than the
non-supplemented animals, although no statical analyses
were performed between the two.

S-hydroxybutyrate arterial concentrations increased, a
trend seen in fasted animals, but one which was observed

numerically but not significantly during energy restriction
in the previous non-lasalocid supplemented work on 50%

energy restriction.

In the previous study, portal drained

viscera S-hydroxybutyrate release decreased and there was a
concomitant increase in hepatic output, resulting in no

change in total splanchnic release and increased arterial
concentrations.

However, in lasalocid fed animals portal

drained viscera release did not change significantly.
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resulting in an increase in total splanchnic release.
Therefor, the rise in arterial concentrations may very well
have been a result of the increased hepatic release.

Total portal drained viscera ketone body release rates
were also numerically greater than the previous energy

restriction study.

When total ketone body production was

expressed as a percentage of total butyrate production,
both studies revealed that approximately 90% of ruminal

butyrate produced was converted to ketone bodies.

A

butyrate conversion rate of 90% has been demonstrated by
other researchers as well (Weigand, et al., 1975).

However, it appears that lasalocid supplementation did
increase the amount of acetate produced, while S-

hydroxybutyrate production remained about the same.

This

coincides with data produced from rumen epithelium studies
from lasalocid supplemented animals (B. Housewright,
unpublished data), indicating that lasalocid may be
changing redox potentials within rumen epithelium cells.
Volatile Fatty Acid Metabolism:
All of the major volatile fatty acids - acetate,

propionate and butyrate - demonstrated a decrease in portal
concentration with energy restriction.

At 100% ME, all

major volatile fatty acid portal concentrations were
numerically higher in lasalocid fed animals verses data
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obtained in the previous non-lasalocid supplemented energy

restriction study, however, no statistical analyses were

performed between the two.

At 50% ME, the portal volatile

fatty acid concentrations were very similar between the two
studies, indicating that lasalocid may not prove beneficial
to animals in a feed restriction induced negative energy
balance.

Acetate arterial concentrations decreased almost 50%

with energy restriction.

The majority of the decrease was

probably due to a nearly 75% decrease in total splanchnic
release.

Hepatic flux was not significantly different,

however, portal drained viscera release decreased
approximately 60%.

These changes were also seen in the

previous study, indicating that ionophore supplementation
did not affect the trends associated with energy

restriction.

Rump data in 50% animals was not available

due to losses in catheter patency (see Materials and
Methods).

Much attention has been given to propionate metabolism
in ionophore supplemented animals.

However, most of the

work has been performed in animals in a positive energy
balance, and there has been little change in propionate

metabolism reported except for changes in ruminal
concentrations.

In this study, there was a significant

decrease in arterial propionate concentrations, which was
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not seen in the previous non-lasalocid supplemented, energy-

restricted study.

This may have been due to an increased

level of circulating propionate which resulted from a total

splanchnic release which was almost 50% greater than in the
previous study, although no statistical analyses were
performed between the two.

Harmon's laboratory has

published contrasting data in this area.

Harmon and Avery

(1987) showed an increase in arterial propionate, but no

change in total splanchnic release.

However, Harmon et al.

(1993) showed no change in arterial propionate
concentrations, but stated that differences in diets may
account for some of the variability associated with
ionophore data.

Both studies were performed in cattle

utilizing monensin and the diets contained variable amounts
of concentrates

Portal drained viscera and hepatic fluxes

of propionate both decreased with energy restriction, which
was similar to trend observed in the previous study,
although there was no change in hepatic extraction.
Perhaps, intact lasalocid released from the gut (Spears,
1990; Donoho, 1984) may have altered this aspect of liver
metabolism.

There was no change in total splanchnic butyrate
release, which was not different from zero.

This occurred

because the decrease in hepatic uptake paralleled the
decrease in portal drained viscera release, which has been
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previously demonstrated earlier by Bergman and Wolff
(1971).

However, there was an unexpected decrease in

arterial concentration, but because the values were so low
this is not believed to be of great physiological
importance.

The changes in both butyrate and valerate seen in this
study were very similar to those seen in the previous study
indicating that lasalocid supplementation had very little
effect on butyrate or valerate metabolism.

Both isobutyrate and isovalerate portal drain viscera
flux decreased significantly, as did hepatic uptake of
isovalerate.

However since concentrations of these acids

are so low, it is difficult to interpret the physiological
significance of these events.
CONCLUSION

The amount of energy released as ketone bodies and

volatile fatty acids is shown in Table 12.

Lasalocid

caused an increase in the molar quantities of the major

volatile fatty acids - acetate, propionate and butyrate -

appearing in the portal vein and, consequently, increased
the amount of energy released by portal drained viscera in
the ewes fed 100% ME only, when compared to results

obtained in the previous study.

The ionophore did not

appear to affect the amount of energy released by the
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portal drained viscera in ewes fed 50% ME, in fact, the
amount of energy released was very similar to the previous

energy restriction study, which suggest that Lasalocid may
not alter rumen metabolism similarly in both positive and
negative energy balances.

Therefore, from the data

obtained in this experiment, it appears that Lasalocid may
not be beneficial to animals fed only 50% of National
Research Council (1984) recommendations for metabolizable
energy.
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Tcdsle 12

Energy release as VFA or ketone bodies from portal
drained viscera of sheep fed at 50% or 100% of NRC

requirements for ME plus ionophore
100%

Acetate

Propionate
Butyrate

Isobutyrate

50%

%Decrease

63

1776
866
106

649
224
38

72
57
90

31

57
42

74
64

fi-Hydroxybutyrate

596

33
45
484

Acetoacetate

166

62

62

3729

1566

58

Valerate
Isovalerate

Total
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50
19

Literature Cited

117

Literature Cited

Armmentano, L. E. and J. W. Young. 1983. Production and
metabolism of volatile fatty acids, glucose and CO2 in
steers and the effects of monensin on volatile fatty
acid kinetics. J. Nutr. 113:1265.

Baird, G. D., 1977. Aspects of ruminant intermediary

metabolism in relation to ketosis. Biochm. Rev 5:819.

Bergen, W. G. and D. B. Bates. 1984. lonophores: There
effect on production efficiency and mode of action.
J. An. Sci. 58:1465.

Bergen, W. G. and M. T. Yokoyama. 1977. Productive limits
to rumen fermentation. J. An. Sci. 46:573.

Bergman, E. N. 1971. Hyperketonemia-ketogenesis and ketone
body metabolism. J. Dairy Sci. 54(6):936.

Bergman, E. N., M. L. Katz, and C. F. Kaufman. 1970.
Quantitative aspects of hepatic and portal glucose
metabolism and turnover in sheep. Am. J. Physiol.

219(3):785.

Bergman, E. N. and J. E. Wolff. 1971. Metabolism of
volatile fatty acids by liver and portal-drained
viscera in sheep. Am. J. Physiol. 221(2):586.

Burrin, D. G., C. L. Ferrell, J. H. Eisemann, R.A. Britton

and J. A. Nienaber. 1989. Effect of level of nutrition

on splanchnic blood flow and oxygen consumption in
sheep. Br. J. Nutr. 62:23.

Chalupa, W. 1977. Manipulating rumen fermentation. J. An.
Sci. 46:585.

Chen, M. and M. J. Wolin. 1979. Effect of monensin and

lasalocid-sodium on the growth of methanogenic and

rumen saccharolytic bacteria. App. Envir. Micro.
38(1):72

Delfino, J., G. W. Mathison and M. W. Smith. 1988. Effect
of lasalocid on feedlot performance and energy

partitioning in cattle. J. An. Sci. 66:136.

Dennis, S. M., T. G. Nagaraja, and A. D. Dayton. 1986.

Effect of lasalocid, monensin and thiopeptin on rumen

protozoa. Res. Vet. Sci. 41:251.

118

Donoho, A. L. 1984, Biochemical studies on the fate on
monensin in animals and in the environment. J. An.
Sci. 56:1528.

Emery, R. S., J. S. Leisman and T. H. Herdt. 1992.
Metabolism of long chain fatty acids by ruminant
liver. J. Nutr. 122:832.

Harmon, D. L. and T. B. Avery. 1987. Effects of dietary

monensin and sodium propionate on net nutrient flux in
steers fed a high-concentrate diet. J. An. Sci.

65:1610.

Harmon, D. L., K. L. Gross and T. B. Avery. 1989. Influence

of ionophore addition to a high-concentrate diet on

net nutrient flux in steers. Nutr. Rep. Internation.

40(6):1127.

Harmon, D. L., K. K. Kreikemeier and K. L. Gross. 1993.
Influence of addition of monensin to an alfalfa hay

diet on net portal and hepatic nutrient flux in
steers. J. An. Sci. 71:218.

Heitmann, R. N., S. C. Sensenig, C. K. Reynolds, J. M.
Fernandez and D. J. Dawes. 1986. Changes in energy

metabolite and regulatory hormone concentrations and
net fluxes across splanchnic and peripheral tissues in
fed and progressively fasted ewes. J. Nutr. 116:2516.

Judson, G. J. and R. A. Leng. 1973. Studies on the control
of gluconeogenesis in sheep: effect of propionate,
casein and butyrate infusions. Br. J. Nutr. 29:175.

Katz, M. L. and E. N. Bergman. 1969. A method for
simultaneous cannulation of the major splanchnic blood

vessels of the sheep. Am. J. Vet. Res. 30(4):655.

Leat, W. M. P. and E. J. H. Ford. 1966. Utilization of free

fatty acids by starved and pregnant sheep. Biochm. J.
101:317.

Mineo, H, T. Yasuda, M. Akiyama, T. Oyamada, S. Kato and
J.Ushijima. 1991. Effect of feeding on hepatic and
portal blood flow in sheep. Sm. Ruminant Res. 5:181.

119

Muntifering, R. B., B. Theurer and T. H. Noon. 1981.
Effects of monensin on site and extent of whole corn

digestion and bacterial protein synthesis in beef

steers. J. An. Sci. 53:1565.

Nagaraja, T. G., M. B. Taylor, D. L. Harmon and J. E.
Boyer. 1987. In vitro lactic acid inhibition and

alterations in volatile fatty acid production by
antimicrobial feed additives. J. An. Sci. 65:1064.

National Research Council. 1984. Nutrient requirement of

sheep. National Academy Press, Washington, DC.

Orskov, E. R. 1977. Capasity for digestion and effects of
composition of absorbed nutrients on animal
metabolism. J. An. Sci. 46:600.

Orskov, E. R., D. A. Grubb, J. S. Smith, A. J. F. Webster
and W. Corrigall. 1979. Efficiency of utilization of
volatile fatty acids for maintenance and energy
retention by sheep. Br. J. Nutr. 41:541.

Painter, G. R. and B. C. Pressman. 1985. Cation complexes
of the monovalent and polyvalent carboxylic

ionophores: lasalocid (X-537A), monensin, A23187

(calimycin) and related antibiotics. In: Metal ions in

biological systems (vol. 19). H. Sigel (ed.). p229.
Marcel Dekker, Inc., New York.

Pressman, B. C. 1976. Biological applications of
ionophores. An. Rev. Biochm. 45:501.

Quigley, J. D. Ill, Z. P. Smith and R. N. Heitmann. 1991.
Changes in plasma volatile fatty acids in response to
weaning and feed intake in young calves. J. Dairy Sci.
74:258.

Reynolds, P. J., G. B. Huntington and C. K. Reynolds. 1986.
Determination of volatile fatty acids, lactate and S-

hydroxybutyrate in blood by ion exchange cleanup and

gas chromatography. J. An. Sci. 63(1):424.

Ricke, S. C., L. L. Berger, P. J. van der Aar and G. C.

Fahey, Jr. 1984. Effects of lasalocid and monensin on

nutrient digestion, metabolism and rumen
characteristics of sheep. J. An. Sci. 58:194.

120

Rogers, J. A. and C. L. Davis. 1982. Rumen volatile fattyacid production and nutrient utilization in steers
fed a diet supplemented with sodium bicarbonate and
monensin. J. Dairy Sci. 65:944.
Russell, J. B. and H. J. Strobel. 1989. Effects of

ionophores on ruminal fermentation. App. Envirn.
Micro. 55:1.

Schelling, G. T. 1984. Monensin mode of action in the
rumen. J. Ani. Sci. 58:1518.

Shetty, P. S. 1990. Physiological mechanisms in the
adaptive response of metabolic rates to energy
restriction. Nutr. Res. Rev. 3:49.

Smith, G. E. 1971. Energy metabolism and metabolism of the
volatile fatty acids. In: Digestive physiology of
ruminants (1st. ed). D. Church (ed.). p601. 0 and B
Books, Inc., Corvalis, OR.

Spears, J. W. 1990. lonophore and nutrient digestion and
absorption in ruminants. J. Nutr. 120:632.
Van Maanen, R. W., J. H. Herbin, A. D. McGilliard and J. W.

Young. 1978. Effects of monensin on in vivo rumen

propionate production and blood glucose kinetics in
cattle. J. Nutr. 108:1002.

Weigand, E., J. W. Young, A. D. McGilliard. 1975. Volatile
fatty acid metabolism by rumen mucosa from cattle fed
hay of grain. J. Dairy Sci. 58:1294.
Williamson, D. H., J. Mellanby and H. A. Krebs. 1962.

Enzymatic determination of D(-)-E-hydrobutyric acid
and acetoacetic acid in blood. Biochm J. 82:90.

Zanzalari, K. P., R. N. Heitmann, J. B. McLaren and H. A.

Fribourg. 1989. Effects of endophyte-infected fescue
and cimetidine on respiration rates, rectal
temperatures and hepatic mixed function oxidase

activity as measured by hepatic antipyrine metabolism

in sheep. J. An. Sci. 67:3370.

121

APPENDICES

122

APPENDIX 1

123

GLUCOSE ANALYSIS

Whole blood glucose determination utilizing the Sigma
Chemical Company Glucose Procedure No. 510 Kit is based on
the following reactions:

1) glucose + 2H2O + O2

glucose oxidase

2) H2O2 + o-Dianisidine

> gluconic acid + 2H2O2

peroxidase

(colorless)

> oxidized o-Dianisidine
(brown color)

Reagents (included with }cit) :

A) PGO enzymes (500 units glucose oxidase, 100

Purpurogalin units peroxidase and buffer salts),

Catalog No. 510-6.
B) o-Dianisidine Dihydrochloride, Catalog No. 510-50.

C) Glucose Standard Solution (100 mg/dl), Catalog No.
635-100.

Other Reagents:

A) 0.3N Barium Hydroxide Solution, Sigma Catalog No.
14-3.

B) 0.3N Zinc Sulfate Solution, Sigma Catalog No. 14-4.
Reagent Preparation:

A) Color Reagent: one capsule o-Dianisidine
Dihydrochloride diluted with 20 ml H2O.
B) Enzyme Solution: one capsule PGO enzymes diluted
in 100 ml H2O.
C) Enzyme-Color Reagent Solution: 1.6 ml of color
reagent is added to 100 ml enzyme solution.
D) All reagents should be stored in amber bottles at
0-5°C.

Procedure:

1) Tubes are labeled STD, BLANK, sample 1, etc. and

1.8 ml H2O is added to all tubes.
2) The blank receives an additional .2 ml H2O, the

STD receives .2 ml glucose and each sample tube
receives .2 ml of the respective whole blood sample
3) 1.0 ml of barium hydroxide is added to all tubes;
vortex.
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4) 1.0 ml of zinc sulfate is added to all tubes;
vortex.

5) Tubes are centrifuged at 3 g for 15 min.
6) .2 ml of the resulting clear supernatant is then
transferred to a new set of tubes labeled as above.

7) To each tube add 2.0 ml of the enzyme-color reagent
solution.

8) Tubes are then incubated for in a 37°C water bath

for 30 min. or allowed to equilibrate at room
temperature for 45 min.
9) Absorbance is measured at 450 nm. All readings
should be completed within 30 min.
Calculations:

Absorbance of unknown

Serum Glucose (mg/dl) =

x 100
Absorbance of standard
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NEFA ANALYSIS

Plasma nonesterifled fatty acid concentrations can be
determined using a WAKO NEFA C kit which is based upon the
following reactions:

1) NEFA + ATP + Coenzyme A

> Acyl-CoA + AMP + PP^

acyl-CoA synthetase

2) Acyl-CoA + O2

> 2,3-trans-enoyl-CoA + H2O2

acyl-CoA oxidase

3) 2H2O2 + MEHA + 4-AAP
product

> Purple colored end

peroxidase

+ 4 H2O

MEHA = 3-methyl-N-ethyl-N-(S hydroxyethyl)-aniline
4-AAP = 4-aminoantipyrine
Reagents (included with kit):
A) Color Reagent A:
Acyl-coenzyme A synthetase
Ascorbate oxidase

Coenzyme A
ATP
4-AAP

B) Diluent for Color Reagent A:
Phosphate buffer
Magnesium chloride
Surfactant
Stabilizers

C) Color Reagent B:
Acyl-coenzyme A oxidase
Peroxidase

D) Diluent for Color Reagent B:
MEHA

Surfactant

E) NEFA Standard Solution:

Oleic acid (1000 /xeq/L)
Surfactant
Stabilizers
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Reagent Preparation:
A) Color Reagent A Solution: Mix 10 ml of Diluent for
Color Reagent A with one vial of color reagent A.

Gently invert bottle until powder is completely

dissolved, then add 13.3 ml H2O.

Store at 2®C to

dissolved, then add 33.3 ml H2O.

Store at 2°C to

ICC until ready to use.
B) Color Reagent B Solution: Mix 20 ml of Diluent for
Color Reagent B with one vial of color reagent A.
Gently invert bottle until powder is completely
10°C until ready to use.
C) Standards: dilute NEFA standard solution provided

with H2O to provide standards of 125, 250, and 500
^eq/L.

Sample Collection and Preparation:
Blood should be collected using a suitable

anticoagulant, such as EDTA.

Heparin use may yield

inaccurate results due to activation of hormone sensitive

lipase. After adding whole blood and anticoagulant, tubes
should be spun at 3 g for 15 mins. to provide the plasma
fraction necessary. This test may also be run on serum by
adding whole blood to a clotting tube and harvesting the
serum after centrifugation. Samples which are hemolyzed or
overtly icteric may yield inaccurate results.
Procedure:

1) Tubes are labeled as standards (e.g. 0, 125, 250,
etc.) and as samples in duplicate.

2) Add .4 ml H2O to all tubes.
3) Add 25 urn of serum, plasma or standard to the
appropriate tube, followed by 350 (ih of Color
Reagent A Solution. Vertex.

4) Incubate in a 37° waterbath for exactly 20 min.
5) After removing from waterbath, add 800 fih of Color
Reagent B Solution to all tubes. Vortex.

6) Incubate in a 37° waterbath for exactly 20 min.
7) Remove tubes from bath and allow to equilibrate at
room temperature for 5 mins.
8) Record OD at 550 nm.

9) Calculation of sample values should be made against
a new standard curve each time the assay is run.
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ACETOACETATE ANALYSIS
Principle

The acetoacetate analysis is a spectrophotometric
determination based upon a compound's (nicotinamide adenine

dinucleotide, NAD, in this analysis) unique property to

absorb a specific quantity of light of specific wavelength,

Acetoacetate is indirectly determined from the
concentration of NAD following the chemical reaction:

HOOC-CH2-CO-CH3 + NADH + H"*"
acetoacetate

» HOOC-CH2-CHOH-CH3 + NAD"^

beta-hydroxybutyrate

Acetoacetate is reduced, in a 1:1 stoichiometry, using
reduced nicotinamide adenine dinucleotide (NADH) in the

presence of the enzyme beta-hydroxybutyrate dehydrogenase
resulting in the formation of beta-hydroxybutyrate and

oxidized nicotinamide dinucleotide (NAD"*").

The change in

absorption between the reduced and the oxidized forms of

nicotinamide adenine dinucleotide results in the
calculation of acetoacetate.
Treatment of Blood

1) Mix equal volumes of whole blood and 1 M HCLO4
immediately after sampling,

2) Centrifuge at 3 g for approximately 15 minutes.
3) Neutralize excess HCLO4 with KOH so that the final
pH is between 6,0 and 8,0,

4) Centrifuge off the potassium perchlorate formed at
approximately 3 g for 15 minutes and then pipette
from the

supernatant,

5) Samples must be analyzed the day of collection.
Reagents

1)

0,1 M Phosphate Buffer (pH 6,8)

1,36 g KH2PO4

►

100 ml dH20

1,74 g K2HPO4

»

100 ml dH20

Mix equal volumes of each solution.
one or the other to balance pH,
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Check pH and add

2)

NADH (approx. 1 inM) (Disodium Salt) (Grade II, 98%
Pure)

(Boehringer Mannheim, cat. # 128023)
0.010 g NADH

»

6.0 ml dH20

Make up on day of use.

3)

3-Hydroxybutyrate Dehydrogenase (5.0 mg/ml)

4)

1.5 mM Acetoacetic Acid (ACAC) (Lithium Salt)
(90 to 95% Pure) (Sigma Chemical Co., cat. # A-

(Grade II) (Boehringer Mannheim, cat. # 127841)

8509)

0.01620 g CH3COCH2COOH

» 100 ml dH20

Standards

Dilute to the following concentrations for the working

standards:

0.15, 0.09, 0.075, 0.045, and 0.0225 mM.

Use two zero concentration standards as blanks.

The standards must be taken through the entire

procedure as small amounts of perchlorate will affect
enzyme activity. Pipette into conical centrifuge
tubes:

1.0 ml standard and 1.0 ml of 1 M HCLO4.

Neutralize to pH 6.0 to 8.0.

(Remember to record the

volume of buffer added to adjust pH !!!).

Centrifuge at 3 g for 15 minutes.
Standard dilutions:

A) 0.15

*

B) 0.09

► 12.0 ml of A plus 8.0 ml dH20

C)

»

0.075

2.0 ml of 1.5 mM ACAC plus 18.0 ml dH20

4.0 ml of A plus 4.0 ml dH20

D) 0.045

» 10.0 ml of B plus 10.0 ml dH20

E) 0.025

» 10.0 ml of D plus 10.0 ml dH20
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Analysis Pipette into 12 X 75 mm culture tubes:
0.5 ml buffer

Sample - 0.25 ml plus 0.75 ml dH20
Standard - 1.0 ml
0.05 ml NADH
Read

at 340 nm.

Add 0.005 ml 3-Hydroxybutyrate Dehydrogenase, vortex,
and incubate at room temperature for approximately 22
minutes.

Read E2 at 340 nm.
Important

NADH will "react" slowly at room temperature but at

about the same rate in all samples.

The zero concentration

ACAC standards can be used as a control for this. Pipette
NADH into all of the cuvettes at known time intervals,

i.e., 15 to
60 s. Then read E^ in all cuvettes at same
timed intervals. Incubate and read E2 at same timed
intervals.

Calculations

Calculate E^ minus E2 for all standards, samples and
blanks:

Change in E of standard minus change in E of blank.
Change in E of sample minus change in E of blank.
Plot a standard curve of change in E of standard
versus concentration.

Read the concentration of the samples from the curve.

Multiply by appropriate dilution factors.

132

APPENDIX 4

133

BETA-HYDROXYBUTYRATE ANALYSIS

Principle

The beta-hydroxybutyrate analysis is a
spectrophotometric determination based upon a compound's
(nicotinamide adenine dinucleotide, NAD, in this analysis)

unique property to absorb a specific quantity of light of
specific wavelength. Beta-hydroxybutyrate is indirectly
determined from the concentration

of NAD following the

chemical reaction:

HOOC-CH2-CHOH-CH3 + NAD"^

» COOH-CH2-CO-CH3 + NADH + H"^

beta-hydroxybutyrate

acetoacetate

Beta-hydroxybutyrate is oxidized, in a 1:1
stoichiometry, using oxidized nicotinamide adenine

dinucleotide (NAD"^) in the presence of the enzyme beta-

hydroxybutyrate dehydrogenase resulting in the formation of

acetoacetate and reduced nicotinamide dinucleotide (NADH).

The change in absorption between the reduced and the
oxidized forms of nicotinamide adenine dinucleotide results

in the calculation of beta-hydroxybutyrate.
Treatment of Blood

1)

2)
3)

4)
5)

Mix equal volumes of whole blood and 1 M HCLO4
immediately after sampling.
Centrifuge at 3 g for approximately 15 minutes.

Neutralize excess HCLO4 with KOH so that the final

pH is between 6.0 and 8.0.

Centrifuge off the potassium perchlorate formed at
approximately 3 g for 15 minutes and then pipette
from the supernatant.

Samples must be analyzed the day of collection.

Reagents

1)

0.1 M Tris-HCL Buffer (pH 8.5)

2.42 g Tris
pH

»

»

50 ml dH20

8.5 with 1 M HCL

Final volume

»

134

200 ml

2)

Hydrazine-Tris Buffer (Burnt Bacon Buffer)
2.5 ml Hydrazine Hydrate
0.05 g EDTA
12.5 ml 1 M HCL

Volume

» 50 ml with Tris-HCL Buffer

Check pH, should be 8.5
Make up on day of use.

3)

14 mM NAD"^ (Free Acid) (Grade II, 98% Pure)
(Boehringer Mannheim, cat. # 127990)

0.06 g MAD"^

» 3.0 ml dH20

3)

3-Hydroxybutyrate Dehydrogenase (5.0 mg/ml)

4)

2.0 mM 3-Hydroxybutyric Acid (Sodium Salt)
(98% Pure) (Sigma Chemical Co., cat. # H-6501)

(Grade II) (Boehringer Mannheim, cat. # 127841)

0.0656 g CH3CHOHCH2COOH

»> 250 ml dH20

Standards

Dilute to the following concentrations for the working

standards:

2.0, 1.6, 1.2, 0.8, and 0.4 mM.

Use two zero concentration standards as blanks.

The standards must be taken through the entire

procedure as small amounts of perchlorate will affect
enzyme activity. Pipette into conical centrifuge
tubes:

1.0 ml standard and 1.0 ml of 1 M HCLO4.

Neutralize to pH 6.0 to 8.0.

(Remember to record the

volume of buffer added to adjust pH !!!).

Centrifuge at 3 g for 15 minutes.
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standard dilutions:

A) 2.0 -

>

20.0 ml of 2.0 mM BOHB

plus 0.0 ml dH20

B) 1.6 -

>

16.0 ml of 2.0 mM BOHB

plus 4.0 ml dH20

C) 1.2 -

»

12.0 ml of 2.0 mM BOHB

plus

D) 0.8 -

>

8.0 ml of 2.0 mM BOHB

plus 12.0 ml dH20

E) 0.4 -

>

4.0 ml of 2.0 mM BOHB

plus 16.0 ml dH20

Analysis

Pipette into 12 X 75 mm culture tubes:
0.5 ml buffer

Sample - 0.10 ml plus 0.90 ml dH20
Standard - 0.25 ml plus 0.75 ml dH20
0.05 ml NAD+

Read El at 340 nm.
Add 0.005 ml 3-Hydroxybutyrate Dehydrogenase, vortex,
and incubate at room temperature for approximately 45
minutes.

Read E2 at 340 nm.
00

Important

0
3

NAD"^ and hydrazine form a complex which absorbs at 340

nm. Therefore, a slow constant increase in absorbance
occurs. This is similar to the acetoacetate assay but
to

in reverse.

So pipette the NAD"*" and enzyme and take0

the absorbance readings at timed intervals as
described for the acetoacetate assay.
Calculations

Same as for acetoacetate, except change in E is
calculated from E2 minus Ei.
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VOLATILE FATTY ACID ANALYSIS

Volatile fatty acid concentrations were determined in
plasma based on the method of Reynolds et. al. (1986), with
modifications by Quigley et al (1991). The exact procedure
is described below.

Reagents:

A) H20/Triton-X mixture (20 fil Triton-XlOO/ 250 ml H2O)

B)
C)
D)
E)
F)
G)

IM Sodium Hydroxide (NaOH)
lOmM Sodium Hydroxide (NaOH)
IN Hydrochloric acid (HCl)
0.3N Zinc Sulfate (ZnS04)
0.3N Barium Hydroxide (BaOH)
Internal Standard ( 1.31mM 2-ethylbutyric acid)

H) O.OIM Oxalic acid
Note: The concentrations of zinc sulfate and barium

hydroxide must completely neutralize each other.
Column Preparation:
A) Paclcing:
1) Anion columns are prepared using BIO-REX 5
resin (100-200 Mesh, Bio-Rad Cat. No. 140-7841)
2) Cation columns are prepared using AG SOW-8
resin (100-200 Mesh, Bio-Rad Cat. No. 142-1441)
3) Resins are first prepared by making a slurry

of each and pouring off fines.

Stir resins twice

more and allow to settle, removing fines each
time.

4) Stir slurry once again and transfer resins
into columns (Poly-Prep Columns, Bio-Rad Cat. No.
731-1550).

5) Each column receives:

a) Cation column receives 1.8 ml resin
b) Anion column receives 0.6 ml resin
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B) Regeneration:
1) Cation

a) Fill columns with IM NaOH and stir resin
b) Rinse twice with water
c) Fill columns with IN HCl twice

d) Rinse twice with H2O
2) Anion

a) Fill columns twice with IM NaOH and stir
resin with first filling

b) Rinse twice with H2O
Notes:

1) Columns must be stores generated and resin must not
be allowed to dry out

2) Stirring columns more often will minimize

establishment of channels through resin
Assay:

A) Regenerate columns, as above, and fill with H2O
B) In 50 ml centrifuge tubes:

1) add 6 ml H20/Triton-X mixture
2) add 2 ml plasma; vortex

3) let stand 5 minutes

4) add 4 ml BaOH; vortex ; let stand 5 minutes

5) add 4 ml ZnS04 vortex ; let stand 5 minutes

6) centrifuge for 15 min. at 13,000 rpm (15,000g)
C) After centrifugation, pour supernatant into 50 ml
tube

D) Add 0.2 ml internal standard to all tubes

E) Allow H2O to drain from columns, then place cation
columns on top of anion columns.

F) Pour supernatnant/internal standard mixture onto
the cation columns.
columns completely

Allow to drip through both

G) Rinse tube twice with 2 ml H2O and pour over
columns, allowing each rinse to drip through
completely

H) Rinse top column once with 2 ml H2O, allow to drip
through
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I) Remove top columns.

Fill columns with H2O

J) Rinse bottom column once with 2 ml H2O, allow to

drip through

K) Place a vial beneath each bottom column; add 10 ml

of 10 mM NaOH and allow to drip through completely; pH

of collected liquid should be above 11, check at least
one sample in each rack

L) Place vials in convection oven until dry

(Temperature should not exceed 50°C)

M) Reconstitute dry sample with 1 ml O.OIM oxalic acid
N) Add 0.1 ml of regenerated cation resin to solution
0) Allow sample to stand for one hour

P) Solution is filtered using a 0.45 /xm syringe filter

(Aerodisc* No. 4184, Gelman Science) and transferred

to a gas chromatograph vial and capped

Q) Samples were analyses for volatile fatty acids by
gas chromatography (30 m x 0.53 mm x 1.0 /xm capillary
column coated with stabilwax-DA, flame ionization

detector, helium carrier at 6 ml/min.) using a Hewlett
Packard model 5890 gas chromatograph.

R) Sample acid concentrations were corrected for

recovery of internal standard

140

APPENDIX 6
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PARA-AMINOHIPPURIC ACID ANALYSIS

Reagents for Filtrate:

1)

Double Distilled (DD) H2O

2)

20% Tricloroacetic Acid (TCA) (CCL3COOH)
(Sigma Chemical Co., cat. # T-6399)

Method for Filtrate:

1) Pipette 1.0 ml of blood or standard into 15 ml

centrifuge tube containing 5.0 ml DD H2O.

2) Pipette 5.0 ml of blood or standard mixture into

second 15 ml centrifuge tube containing 5.0 ml 20%
TCA.

3) Let stand 60 min or overnight (can be left at this
stage if refrigerated).
4) Filter through Whatman #4 filter paper into 16 x
150 mm glass culture tubes.

5) Add boiling chip to each culture tube and place a
marble on top of each tube.

6) Boil over low heat in water bath for 30 min after
fine bubbles appear in each tube.

7) Cool at room temperature and remove marbles when
cool.

8) Standards from 1.5% PAH infusion solution are made

along with this using same method as for blood
filtrate. Make up a 1:500 dilution for sheep from
1.5% infusion solution; 1:100 for dog from 0.25%
infusion solution (considered 10:10).
Notes:

1) Be sure to run this dilution through the filtrate
procedure (do not boil).

2) Blank mixed with half DD H2O and half TCA (20%).
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Reagents for Analysis:
1)

1.2 N Hydrochloric Acid (HCl)
(Fisher Scientific Co., cat. # A-144-S)
(1:10 dilution of 12.4 N HCl is adequate)

2)

Sodium Nitrite (NaN02)
(Sigma Chemical Co., cat. # S-2252)
ICQ mg NaN02
> 100 ml H2O

3) Ammonium Sulfamate (NH4OSO2NH2)
(Sigma Chemical Co., cat. # A-8670)
500 mg Ammonium Sulfamate
> ICQ ml H2O

4) Coupling Reagent N(-1-Naphthyl)Ethylenediamine
(Sigma Chemical Co., cat. # N-5889)
500 mg coupling reagent
> 100 ml H2O

All reagents should be refrigerated in brown bottles
and can be stored indefinitely.

Analysis:

1) Pipette 1.0 ml of filtrate, standard or blank

test tube (in duplicate).

into

2) Add 0.2 ml of 1.2 N HCl to all tubes and vortex.
Start time clock and add to all tubes:
a) 0.1 ml sodium nitrite
b) 0.1 ml ammonium sulfamate
c) 0.1 ml coupling reagent

3) Wait 10 min (minimum) for color development.
4) Read absorbance on spectrophotometer at 540 nm.

5) Calculations are made as a percentage of 100
standard.

Note:The reagents in step 2 should be added with no

more than 5 min between additions and tubes should be

vortexed after each addition.
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PAH Stock Solution:

Reagents:

,, „

1) Para-Aminohippuric Acid (PAH)(Eastman Kodak Corp.,
cat. # 5704)

2) Sodium Hydroxide (NaOH)

(Fisher Scientific Co., cat # S-318)

Procedure:

,

..

.

,

1) Dissolve each reagent separately in Physiological
Sterile Saline (PSS):
a)44.8 g PAH
b)10.5 g NaOH

2) Add NaOH solution to PAH solution and stir. (May
heat gently to fully dissolve.

3) Filter through Whatman #4 filter paper.

4) Titrate filtrate to pH 7.4 with 1 N HCl or 4 M
NaOH.

5) Bring final volume to 500 ml.
Note:

Yields a 1.5% solution of sodium salt.
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